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Abstract 
 
Human cytomegalovirus (HCMV) is a widespread pathogen that causes lifelong latent 
infection.  Successful persistence of HCMV in healthy individuals involves extensive 
manipulation of host cellular functions and immune responses.  HCMV encodes four 
genes for putative G protein-coupled receptors (GPCRs):  US27, US28, UL33, and UL78.  
The US28 gene product is a functional chemokine receptor that exhibits a variety of 
signaling outcomes.  In contrast, the US27 gene product is an orphan with no known 
chemokine ligands.  We have found that US27 triggers several biological effects: 
increased cellular proliferation, changes in gene expression, and enhanced signaling of 
cellular chemokine receptor CXCR4.  Enhanced cell survival and proliferation were 
mediated by the DRY box and C-terminal domain (CTD) of US27.  PCR array analysis 
revealed that expression of US27 led to up-regulation of pro-survival factor Bcl-x, AP-1 
transcription factor components jun and fos, and down-regulation of cell cycle regulators 
CDKN1A (cyclin dependent kinase inhibitor 1A) and SESN2 (Sestrin2 or Hi95).   These 
results indicate that increased cell proliferation due to US27 may be linked to suppression 
of negative growth regulators.  In addition, US27 was shown to increase calcium 
mobilization of CXCR4 in response to its natural ligand CXCL12.  cmvIL-10, an 
ortholog of human IL-10, was also found to enhance CXCR4 signaling and act 
synergistically with US27.  In both HCMV-infected and US27-transfected cells, exposure 
to cmvIL-10 increased calcium and migration responses to CXCR4 ligand CXCL12.  
This cooperative effect may enable HCMV to manipulate CXCR4 to alter host immune 
responses and modify cell trafficking patterns.  Overall, US27 has a wide range of 
functions that may alter activities of HCMV-infected cells.  
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Introduction 
 
Human cytomegalovirus (HCMV), also known as human herpesvirus-5, is a 
widespread pathogen that can lay dormant in healthy individuals and establish lifelong 
latent infection [1].  Seroprevalence ranges from 45-100%  worldwide [2] and while 
infection is generally asymptomatic in healthy individuals, it can be life-threatening in 
immune-compromised hosts [3, 4].  If symptoms do occur upon infection, they are 
typically flu-like [3, 4] or a mononucleosis-like fever [5].  Transplant recipients and 
AIDS patients are more prone to becoming infected with HCMV due to reactivation of 
latent virus, resulting in serious conditions like retinitis and pneumonitis [4].  HCMV also 
remains the most common viral cause of birth defects and childhood disabilities in the 
United States [6]. 
 The HCMV virion is composed of a genome of 230 kb linear double-stranded 
DNA that is enclosed by an icosahedral capsid, which itself is surrounded by a 
proteinaceous layer termed the tegument [7] (Figure 1).  The outermost layer is the viral 
envelope, which consists of a lipid membrane containing glycoproteins for virus 
attachment onto host cells.  HCMV has the largest genome of all herpesviruses, encoding 
over 200 open reading frames (ORF) [8].  Replication of HCMV is relatively slow and 
requires at least 24 hours to produce infectious progeny virions, which are generally not 
released until 72-96 hours later [9].  The viral genome is transcribed slowly in a 
sequential and highly regulated order, and transcription is divided into three major 
phases: immediate-early (IE), early (E), and late (L).  The immediate-early proteins are 
first synthesized and act as transcription factors to activate early genes required for the  
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Figure 1.  Schematic image HCMV virus particle.  The virion of HCMV contains a linear double-
stranded DNA genome packaged in an icosahedral capsid.  The capsid is surrounded by a tegument and 
an enveloped composed of a lipid bilayer membrane.  
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replication process itself.  The late genes are involved in encoding structural virion 
components and are transcribed only after viral DNA replication has begun [9, 10]. 
Upon infection with HCMV, the virus establishes a lifetime coexistence with the 
host through chronic virus shedding and latency [11].  Throughout the chronic infection, 
there is minimal yet constant shedding of the virus in bodily fluids such as urine, blood, 
and saliva.  Latent infection is characterized by a reversibly quiescent state, which 
enables the virus to reactivate and periodically produce viral progeny [12].  HCMV is 
able to maintain a successful coexistence with its host by evading and manipulating the 
immune system.   One strategy involves interference with the major histocompatibility 
complex (MHC).  MHC class I molecules are cell surface glycoproteins that play a role in 
the immune surveillance against viruses by displaying antigens on infected cells, whereby 
the immune cells can recognize and ultimately destroy them [13].  HCMV has been 
shown to down-regulate surface expression of MHC class I, thus preventing antigen 
presentation during the IE phase of infection [14, 15].  HCMV also encodes a viral 
ortholog of MHC class I, which may function as an immune modulator and disrupt the 
presentation of antigens to cytotoxic T cells while also preventing recognition by natural 
killer cells [13, 16].  Mimicking and inhibiting the MHC complex helps contribute to 
viral evasion and protection from the host immune system.  In addition, successful co-
existence of HCMV with a healthy host is also mediated by the production of viral 
proteins that are similar to normal immune modulators like cytokines, chemokines, and 
chemokine receptors [17].    
One such mimic is the HCMV US27 gene product that has seven transmembrane 
domains and similarity to the human chemokine receptor family of G-protein coupled 
Tu,$Carolyn$
! 14!
receptors (GPCRs), including conserved cysteines in the extracellular loops and extensive 
glycosylation of the extracellular domain [18].  US27 also contains a DRY (aspartic acid, 
arginine, tyrosine) motif in the second intracellular loop that is critical in other GPCRs 
for activation of G proteins following ligand binding [19], as well as a di-leucine motif in 
the carboxy-terminal domain that mediates receptor endocytosis [20] (Figure 2).  Despite 
having these characteristics, US27 is considered an orphan since no human chemokine 
ligands have been shown to engage the receptor [20].  US27 is found in the envelope of 
the virus particle [18], but in virus-infected cells, the majority of the US27 protein is 
found in endosomes, the Golgi apparatus, and perinuclear compartments [21].  The US27 
gene is non-essential for virus replication, and mutants that lack US27 are replication 
competent [22].  However, US27 deletion mutant viruses are incapable of spreading via 
the extracellular route in endothelial cells [23], suggesting that US27 might play a role in 
virion assembly or egress.   
Interestingly, HCMV encodes three other genes that give rise to proteins having 
similarity to human chemokine receptors [24, 25].  One of these, US28, has been shown 
to elicit intracellular signaling both constitutively and in response to several human 
chemokines, including CCL3/MIP-1α, CCL5/Rantes, and CX3CL1/Fractalkine [26-28].  
UL33 also has constitutive signaling ability [29], and rodent homologs of both UL33 and 
UL78 have been shown to play a role in virus dissemination in vivo [30, 31].  The M33 
gene of murine cytomegalovirus,  a homolog of HCMV UL33, was found to be required 
for salivary gland tropism and efficient reactivation from latency, and the HCMV US28 
gene was able to complement and partially rescue those deficiencies [32, 33].     
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Figure 2.  Schematic image of the HCMV US27 gene product.  US27 contains conserved cysteines in 
the extracellular loops and contains a DRY (aspartic acid, arginine, tyrosine) motif in the second 
intracellular loop.  
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Recent evidence suggests that US28 forms heteromeric complexes with US27, 
UL33 and UL78 [34].  While no functional changes were observed with the US28:US27 
heteromer, the US28:UL33 heteromer and the US28:UL78 heteromer both ablated 
activation of NF-κB transcriptional activity by US28. This suggests a complex level of 
regulation in which these viral receptors may interact in particular combinations to either 
promote or block signaling through specific pathways in particular cell types or at 
specific times during the course of virus infection.  US27, US28, UL33, and UL78 are all 
likely to play important roles in immune modulation and viral persistence, and the 
presence of multiple receptors in the viral genome could be due to the need to control 
cellular activity in a large variety of cell types infected by HCMV, which include 
monocytes, lymphocytes, epithelial cells, endothelial cells, and fibroblasts [35].   
Considering that GPCRs constitute a major target in pharmaceutical development, 
discerning the function of viral GPCRs during HCMV infection could be highly 
beneficial in the quest for novel anti-viral therapeutics.   
Although no chemokine ligands for US27 have been identified, US27 has been 
shown to enhance cell proliferation, survival [36, 37] and signaling activity of the human 
chemokine receptor CXCR4 [38].   Chemokines, or chemotactic cytokines, and their 
receptors play crucial roles in inflammation by directing immune cells, such as 
leukocytes, to sites of injury or infection [39].  CXCR4 exhibits many physiological 
roles, including chemotaxis, embryogenesis, hematopoiesis, vascularization, and the 
immune response [40].  CXCR4 is a human G-protein-coupled receptor (GPCR) and 
binds to ligands CXCL12/SDF-1α and ubiquitin [41, 42].  CXCR4 signaling plays key 
roles in hematopoiesis and immune homeostasis.  The effects of CXCL12 are mediated 
Tu,$Carolyn$
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through G protein signaling, causing activation of downstream pathways including 
mitogen activated protein kinase (MAPK) family members and PI3K/Akt cascades [43, 
44].  Early studies found CXCR4 to function as a co-receptor for entry of HIV into CD4+ 
T cells [45].  CXCR4 is also found to be up-regulated in many different types of cancer 
cells [46-48], and linked to enhanced tumor growth and metastases [44].  
 While CXCL12-CXCR4 signaling has been found to be down-regulated by both 
viral and cellular GPCRs, such as CCR2 [49], CXCR7 [50], EBV BILF1 [51], and 
HCMV UL33 and UL78 [52], HCMV US27 was shown to potentiate CXCR4 activity 
[38].  In stably-transfected HEK293 cells expressing both US27 and CXCR4, a greater 
calcium mobilization was seen in response to CXCL12 than control HEK293 cells.  
CXCR4 signaling can also be enhanced by other proteins, such as T-cell receptor [53] 
and human IL-10 [54].  Human IL-10 has been shown to potentiate the chemotactic effect 
of CXCL12 in B-lymphocytes, while other cytokines such as IL-5, IL-6, and IL-9 do not 
[54].  Furthermore, IL-10 also increased the effect of CXCL12 on the proliferation and 
survival of B-lymphocytes [54].  In this thesis, we investigated whether cmvIL-10, a viral 
homolog of human IL-10, can also alter CXCR4 activity.   
cmvIL-10, encoded by the UL111A gene, shares only a 27% amino acid sequence 
identity to human IL-10 [55].  Despite this low conservation, cmvIL-10 exhibits the same 
immunosuppressive properties as human IL-10, such as inhibition of pro-inflammatory 
cytokines and T cell proliferation, and down regulation of the MHC expression [56].  
Like human IL-10, cmvIL-10 can also inhibit nuclear factor κB (NF-κB) transcriptional 
activity in human monocytes and suppress pro-inflammatory cytokines TNFα and IL-6 
[57].      
Tu,$Carolyn$
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cmvIL-10 binds and signals through the human IL-10 receptor (hIL-10R) [55]. 
Once the hIL-10R is engaged by its ligand, the receptor dimerizes and activates JAK 
(Janus kinases), which is followed by STAT (signal transducer and activator of 
transcription) recruitment and phosphorylation (Figure 3).  After STAT dimerizes, it will 
translocate into the nucleus and activate genes responsive to STAT.  STATs are key 
integrators of cytokine and growth factor receptor signaling required for cell growth, 
survival, differentiation, and motility [58, 59].  Thus, the virus has the ability to hijack the 
cellular JAK-STAT signaling pathway and manipulate the host immune response.   
In this thesis project, we show that HCMV US27 enhances cell proliferation 
(chapter 1), protects cells from apoptosis and cause changes in host gene expression 
(chapter 2), and affects CXCR4 synergistically with cmvIL-10 (chapter 3).  These 
findings are the first reported biological activities associated with US27 and help shed 
light on the function of this protein during infection.   
 
 
 
 
Tu,$Carolyn$
! 19!
 
 
 
 
 
JAK JAK JAK JAK 
-Y Y- 
cmvIL-10 
IL-10R 
St
at
3 
St
at
3 
-Y 
Y- 
Nucleus 
Increase Signaling  
 
Figure 3.  Schematic image of cmvIL-10 binding to IL-10 receptor.  All three receptors are in close proximity to each other, 
thereby increasing intracellular signaling.  
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Chapter 1 – The human cytomegalovirus US27 gene product enhances cell proliferation 
and alters cellular gene expression  
 
(Lares, A.P., Tu C.C., and J.V. Spencer. 2013 Virus Research 176: 312-320) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tu,$Carolyn$
! 21!
Chapter 1 Introduction to published manuscript 
 
 
In this study, we found that US27 significantly increased both cell proliferation 
and DNA synthesis compared to control cells.  PCR array analysis revealed that 
expression of US27 led to changes in a limited number of cellular genes, but genes that 
were up-regulated included the pro-survival factor Bcl-x, AP-1 transcription factor 
components jun and fos, and the IL-6 family cytokine oncostatin M.   These results 
demonstrate that US27 can impact host cell physiology and may shed light on the 
function of this orphan viral GPCR.  
A former graduate student, Angela P. Lares, started this project and it was a 
privilege for me to carry it on.  My role included confirming expression of US27 and 
control receptors in both western blotting and immunofluorescence staining.  I carried out 
the cell count data and calculated the mean doubling time as another way to confirm that 
measurement of growth was not due to an effect of US27 on ATP levels (per cell) or 
prevention of cell death from transfection.  I also repeated the qPCR arrays to include 
three biological replicates and ensured all plates were set to the same baseline threshold 
for accurate reading of quality controls and comparisons between US27 and controls.  
And lastly, I confirmed that US27 causes up-regulation of AP-1 complex genes jun and 
fos not only on the RNA level, but also the protein level through western blotting. !
Virus Research 176 (2013) 312– 320
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a  b  s  t  r  a  c  t
Human  cytomegalovirus  (HCMV)  is a prevalent  pathogen  worldwide.  Although  generally  harmless  in
healthy  individuals,  HCMV  can  pose  a serious  threat  to immune  compromised  individuals  and  developing
fetuses  in  utero.  HCMV  encodes  four  genes  predicted  to  give  rise  to G protein-coupled  receptors  (GPCRs):
US27,  US28,  UL33,  and  UL78.  The  US28  gene  product  is  a  functional  chemokine  receptor  that  enhances
cell  growth  in  some  cell  types  but  induces  apoptosis  in  others.  In contrast,  the  US27  gene  product  has  not
been  demonstrated  to  signal  either  constitutively  or  in  a ligand-induced  manner.  In this  study,  US27  was
expressed  in  transfected  cells,  and  both  cell  proliferation  and  DNA  synthesis  were  significantly  increased
compared  to control  cells.  PCR  array  analysis  revealed  that  expression  of  US27  led  to changes  in  a  limited
number  of  cellular  genes,  but  genes  that  were  up-regulated  included  the pro-survival  factor  Bcl-x,  AP-1
transcription  factor  components  jun  and  fos,  and  the  IL-6 family  cytokine  oncostatin  M.  These  results
demonstrate  that  US27  can  impact  host  cell  physiology  and  may  shed  light  on the  function  of  this  orphan
viral  GPCR.
© 2013 Elsevier B.V. All rights reserved.
Human cytomegalovirus (HCMV) is a member of the Herpesviri-
dae family, and infection is widespread in the general population
(Staras et al., 2006). While most healthy adults exhibit only
mild or no symptoms of infection, serious disease can occur in
immune compromised individuals, especially AIDS patients, trans-
plant recipients, and newborn infants (Kesson and Kakakios, 2007).
HCMV is the leading infectious cause of birth defects, and congeni-
tal HCMV infection continues to be problematic due to deficiencies
in public awareness, diagnostic procedures, and treatment options
(Revello et al., 2008).
Like all other herpesviruses, the HCMV virion consists of a large
DNA genome enclosed in an icosahedral capsid surrounded by a
dense tegument layer, all encircled in a lipid envelope contain-
ing numerous viral glycoproteins. HCMV has the largest genome
of all the human herpesviruses at 230 kb and encoding at least 167
genes (Mocarski et al., 2006). More than half of these genes are not
required for virus replication in vitro (Yu et al., 2003) but instead
play roles in vivo in the manipulation of host immune responses
and the establishment of latency (Jackson et al., 2011). The US27
gene, which encodes a putative G protein-coupled receptor (GPCR)
found in the viral envelope, is one of these non-essential genes
∗ Corresponding author at: University of San Francisco, 2130 Fulton Street, Harney
Science Center Room 342, San Francisco, CA 94117, USA. Tel.: +1 415 422 5470; fax:
+1  415 422 6363.
E-mail addresses: aspletcher@usfca.edu (A.P. Lares), cctu@usfca.edu (C.C. Tu),
jspencer@usfca.edu (J.V. Spencer).
(Chee et al., 1990; Margulies and Gibson, 2007). Virus mutants
lacking US27 are replication competent (Bodaghi et al., 1998),
although a single log reduction in virus titers produced from both
infected fibroblasts and endothelial cells was  observed (O’Connor
and Shenk, 2011). The US27 deletion mutant virus also exhibited a
defect in extracellular spreading, but the virus was still able to infect
neighboring cells, presumably via the cell-cell route (O’Connor and
Shenk, 2011). The US27 gene is expressed late during infection,
and the gene product is found mainly in the endosomes, the Golgi
apparatus, and perinuclear compartments of infected cells (Fraile-
Ramos et al., 2002).
The US27 gene product has many conserved features of the
chemokine receptor subset of the GPCR superfamily, such as seven
transmembrane domains, a DRY (aspartic acid–arginine–tyrosine)
motif in the second intracellular loop, conserved cysteines (C104
and C176) in the second and third extracellular loops, and exten-
sive glycosylation of the extracellular domains (Margulies and
Gibson, 2007). Despite having these characteristics, US27 is con-
sidered an orphan since no human chemokine ligands have been
shown to engage the receptor (Stapleton et al., 2012). Interestingly,
HCMV encodes three other genes that give rise to proteins hav-
ing similarity to human chemokine receptors (Beisser et al., 2002;
Chee et al., 1990). One of these, US28, has been shown to elicit
intracellular signaling both constitutively and in response to sev-
eral human chemokines, including CCL3/MIP-1!, CCL5/Rantes, and
CX3CL1/Fractalkine (Gao and Murphy, 1994; Neote et al., 1993;
Stropes et al., 2009). UL33 also has constitutive signaling abil-
ity (Casarosa et al., 2003), and rodent homologs of both UL33
0168-1702/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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and UL78 have been shown to play a role in virus dissemina-
tion in vivo (Beisser et al., 1999, 1998). The M33  gene of murine
cytomegalovirus, a homolog of HCMV UL33, was found to be
required for salivary gland tropism and efficient reactivation from
latency, and the HCMV US28 gene was able to complement and
partially rescue those deficiencies (Cardin et al., 2009; Farrell et al.,
2011).
Recent evidence suggests that US28 forms heteromeric com-
plexes with US27, UL33 and UL78 (Tschische et al., 2011). While
no functional changes were observed with the US28:US27 het-
eromer, the US28:UL33 heteromer and the US28:UL78 heteromer
both ablated activation of NF-"B transcriptional activity by US28.
This suggests a complex level of regulation in which these viral
receptors may  interact in particular combinations to either pro-
mote or block signaling through specific pathways in particular
cell types or at specific times during the course of virus infec-
tion. US27, US28, UL33, and UL78 are all likely to play important
roles in immune modulation and viral persistence, and the pres-
ence of multiple receptors in the viral genome could be due to the
need to control cellular activity in the large variety of cell types
infected by HCMV, which include monocytes, lymphocytes, epithe-
lial cells, endothelial cells, and fibroblasts (Mocarski et al., 2006).
Considering that GPCRs constitute a major target in pharmaceutical
development, discerning the function of viral GPCRs during HCMV
infection could be highly beneficial in the quest for novel anti-viral
therapeutics.
To study the function of US27, the gene from HCMV strain
AD169 was cloned into the p3XFLAG expression vector and tran-
siently transfected into HEK293 cells, as described (Stapleton et al.,
2012). The cells were seeded into 96-well plates at a density of
1 × 104 cells per well, and cell proliferation was monitored using
the CellTiter-Glo Assay (Promega, Madison, WI). Briefly, a luciferin
substrate that is converted to oxyluciferin in the presence of O2
and ATP was added to each well. The resulting luminescence is pro-
portional to the amount of ATP present, reflecting the number of
viable cells in the well. Cells expressing US27 had greater lumines-
cence, suggesting that they had an enhanced growth rate compared
to controls, as shown in Fig. 1A. The control cells included mock
transfected cells treated with transfection reagent only, cells trans-
fected with the empty p3XFLAG vector, and cells transfected with
the p3XFLAG vector expressing HCMV US28 or human chemokine
receptor CXCR3, which was cloned from human peripheral blood
mononuclear cells as previously described (Stapleton et al., 2012).
US27-expressing cultures consistently exhibited 14–26% greater
luminescence over the course of the experiment than most of
the other cell lines, which is indicative of higher cell numbers
and a faster growth rate. Each of the other control cell lines had
comparable growth rates except for the US28-expressing cells,
which exhibited reduced luminescence, indicating fewer viable
cells. The transfection efficiency was comparable among the cell
lines at 60–70%, as indicated by staining with an anti-FLAG anti-
body (Sigma–Aldrich, St. Louis, MO), followed by FITC-conjugated
secondary antibody and flow cytometry (Fig. 1B).
To rule out any possibility that the FLAG tag might be affecting
US27 functional activity, the US27, US28 and CXCR3 genes were
also cloned into a pEGFP vector (Clontech, Mountain View, CA) and
expressed as fusion proteins linked to the C-terminal domain of
EGFP. As shown in Fig. 1C, HEK293 cells transiently transfected
with pEGFP-US27 also exhibited greater cell proliferation than cor-
responding control cells. The increase in growth rate for these cells
was more modest, with an increase of 9–16% over each of the con-
trol cell lines over the course of the experiment. The growth of the
pEGFP-US27 transfected cells was 26–30% higher than pEGFP-US28
transfected cells. Transfection efficiency with the pEGFP plasmids
was comparable among the cell lines, but lower than the p3XFLAG
plasmids, at 46–52% (Fig. 1D). Overall, the US27-expressing HEK293
cultures grew faster while US28 cells grew at a reduced rate com-
pared to the control cell lines. These results suggested that the US27
gene product might enhance cell growth.
Previous studies have shown that the US28 gene product may
have different effects on cell growth and survival depending on
cell type. Transient transfection of GFP-US28 induced apoptosis in
293T, HeLa, and Cos cells (Pleskoff et al., 2005), whereas US28 was
found to enhance cell growth and cell cycle progression in stably
transfected NIH-3T3 cells (Maussang et al., 2006). Since we found
increased growth rates associated with US27 and decreased growth
rates with US28 in HEK293 cells, we next transfected and eval-
uated two additional cell types, HeLa and Cos cells (Fig. 1E and
F). The results indicate that these cell types also exhibited greater
proliferation when expressing HCMV US27 than control cells. Cells
expressing US28 were found to have the slowest growth rate, possi-
bly due to the loss of some cells undergoing apoptosis, a result that
would be consistent with previous studies (Pleskoff et al., 2005).
Although we also attempted to examine the effects of US27 in NIH-
3T3 cells, the rate of transfection was extremely low (10%) and
prevented their inclusion in this study.
In order to confirm that the differences in growth rates that we
observed were specifically due to the presence of US27 and not
the result of well-to-well differences in plasmid purity, transfec-
tion efficiency, or transgene expression, stable HEK293 cell lines
were created. Following transfection with p3XFLAG-US27, cells
were cultivated in the presence of 1 mg/ml  geneticin to eliminate
untransfected cells, and clonal cell lines were created using limiting
dilution. As shown in Fig. 2A, comparable levels of FLAG-tagged pro-
tein were expressed in each of the cell lines. CXCR3 was detected as
a 42 kD band, US28 as a 44 kDa band, and US27, which is extensively
glycosylated, was detected as a 45–55 kD smear. Immunofluores-
cence microscopy also indicated that protein expression levels
were comparable among the cell lines (Fig. 2B). When the growth
rate of the stable cell lines was  examined via cell counting, the US27
cultures were found to have significantly higher cell numbers after
72 h (Fig. 2C). Although one representative clonal cell line is shown
here, three individual 293-US27 clonal cell lines were examined
and all had comparable expression levels and growth rates (data not
shown), suggesting that the integration of the expression cassette
did not account for the enhanced proliferation of cells expressing
US27. The mean doubling time was 12.1 h for the 293-US27 cul-
tures, compared to 13.9 h for empty vector transfected cells, 14.4 h
for 293-CXCR3 cells and 17.5 h for 293-US28 cells (Fig. 2D). When
cell proliferation was examined using the Cell Titre-Glo assay, 293-
US27 cells still exhibited significantly greater proliferation (14–25%
higher) than control cells (Fig. 2E). In addition, DNA synthesis was
examined using BrdU incorporation, and the rate of DNA synthesis
was  found to be significantly higher (26–49%) in cells expressing
US27 compared to the control cell lines (Fig. 2F). These results
clearly demonstrate that the HCMV US27 gene product stimulates
cell proliferation and increases the rate of DNA synthesis.
In order to identify cellular genes that might be affected by
the US27 gene product and contribute to the enhanced prolifera-
tive effect observed here, PCR array analysis was performed on the
stable cell lines. RNA was  extracted from each cell type (HEK293,
293-US27, 293-US28, and 293-CXCR3) and expression levels of 84
genes involved in the JAK-STAT signaling pathway were compared
using RT2 Profiler Arrays (SABiosciences, Valencia, CA). For each of
the stable cell lines, three biological replicates were assayed, aver-
aged, and compared to control HEK293 cells, as shown in Fig. 3.
Some genes were found to be up-regulated in a non-specific man-
ner, for example, JUNB expression was increased by more than
2-fold in all three cell lines compared to control HEK293 cells. Other
genes that were up-regulated by all three receptors included MYC,
CEBP, and JAK1, suggesting that overexpression of any GPCR might
yield the induction of a certain subset of inflammatory genes. In
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Fig. 1. Cells expressing HCMV US27 exhibit enhanced cell growth. (A) HEK293 cells were seeded into white 96-well plates at a density of 1 × 104 cells per well and then
transfected with the indicated p3XFLAG expression vectors using Fugene transfection reagent (Roche Biosciences, Basel, Switzerland) at a ratio of 3:1 (#l Fugene:#g plasmid
DNA  per manufacturer’s instructions). Cell number was  monitored via the addition of CellTiter-Glo reagent (Promega, Madison, WI)  at the indicated time points and
luminescence evaluated using a Turner Biosystems Veritas Microplate Luminometer. (B) Transfection efficiency was determined by flow cytometry after staining cells at the
indicated times post-transfection with anti-FLAG antibody and FITC-conjugated secondary in permeabilization buffer. (C) HEK293 cells were seeded and transfected with the
indicated pEGFP expression vectors as described, then cell growth was  monitored using CellTiter-Glo reagent and luminometry. (D) Transfection efficiency was determined
by  flow cytometry for cells expressing EGFP. (E) HeLa cells were seeded at 5 × 103 cells per well and transfected with the indicated pEGFP expression vectors as described,
then  cell growth monitored using CellTiter-Glo reagent and luminometry. (F) Cos7 African green monkey cells were seeded at 1 × 104 cells per well and transfected with the
indicated pEGFP expression vectors as described, then cell growth monitored via the addition of Cell Titer Glo reagent and luminometry. Error bars represent standard error
of  three triplicate data points.
order to eliminate these non-specific effects, the fold change val-
ues for 293-US27 and 293-US28 were then calculated compared
to the 293-CXCR3 values in order identify changes specific to the
viral receptors. A select subset of the results for US27 is shown in
Fig. 4, with a line marking changes of 1.8-fold or higher compared
to controls. A fold change cutoff of 2.0 is recommended by the array
manufacturer, but other sources indicate that fold change values of
1.5 or higher should not be ignored, especially when they indicate
genes that are physiologically relevant (Dalman et al., 2012). We
selected a mid-range cut-off of 1.8-fold change and have identified
seven JAK-STAT pathway genes whose expression level is signif-
icantly increased in the presence of US27: BCL2L1, FCGR1A, JUN,
OSM, SOCS2, SOCS5, and TYK2. Table 1 includes a brief descrip-
tion of each cellular gene significantly impacted by either US27 or
US28, as well as the fold change value for each cell type compared
to cells expressing CXCR3. Six of the seven genes that exhibited
up-regulation by US27 were also up-regulated in the presence of
US28, suggesting that the two viral receptors may  work together
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Fig. 2. Stable cell lines expressing US27 have a shorter doubling time and synthesize DNA at a higher rate than controls. HEK293 cells were transfected with p3XFLAG
vectors and stable, clonal cell lines were produced using antibiotic selection as described (Stapleton et al., 2012). Expression of the transgene was  evaluated via (A) western
blot  staining of cell lysates using anti-FLAG antibody followed by AP-conjugated secondary or anti-total MAPK as a control and (B) immunofluorescence staining of fixed,
permeabilized cells with anti-FLAG antibody followed by FITC-conjugated secondary. (C) Cells were seeded in 6-well dishes at 2 × 105 cells per well, then harvested and
counted using a hemacytometer at the indicated time points. (D) Doubling time was  calculated based on total number of cell divisions for over the 72 h growth period
for  triplicate wells of the standard growth curve. (E) Cell growth was measured via the addition of CellTiter-Glo reagent and luminometry. (F) The rate of DNA synthesis
for  HEK293 stable cell lines was  measured using bromodeoxyuridine (BrdU) incorporation (Roche Bioscience, South San Francisco, CA) and luminometry at the indicated
times. Error bars represent standard error of three triplicate data points. Statistical analysis was performed by Student’s t-test and * indicates p < 0.05. These results are
representative of four independent experiments.
to enhance expression of certain cellular genes that foster a favor-
able environment for virus infection. The seventh gene, BCL2L1,
was up-regulated by US27 but down-regulated in cells expressing
US28.
In addition to the JAK-STAT array, genes involved in GPCR
signaling were also evaluated via the RT2 Profiler Array System.
Expression profiles for each cell type compared to HEK293 cells
are shown in Fig. 5. Again, certain genes were up-regulated by the
expression of all three GPCR, including AGTR1, CALCR, and CASR,
suggesting that these effects are non-specific and might be induced
by the overexpression of any GPCR. When the fold change values
for 293-US27 and 293-US28 were compared to the 293-CXCR3
values, only three cellular genes were found to be significantly
up-regulated by HCMV US27: FOS, JUN and CYP19A1, as shown
in Table 2. A greater number of cellular genes were impacted by
US28, which also caused upregulation of CYP19A1, as well as CAL-
CRL, CCL2/MCP-1, OPRK1, PI3CG, and PTGS2. Notably, expression of
BCL2L1 and ADRB1, the $-adrenergic receptor, were significantly
down-regulated by US28 compared to controls. There were two
genes that were represented on both the JAK/STAT array and the
GPCR array: BCL2L1 and JUN. JUN was found to be significantly up-
regulated in the presence of US27 on both arrays, while the BCL2L1
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Fig. 3. JAK-STAT pathway gene expression levels in cells expressing US27, US28, or CXCR3. RNA from stable cell line was extracted using RNEasy Midi Kit (Qiagen, Valencia, CA),
cDNA  was  prepared using the RT2 First Strand Kit (Qiagen), and then diluted cDNA was  mixed with the RT2 SYBR green master mix  (Qiagen) according to the manufacturer’s
instructions and loaded into the Human Jak-Stat RT2-PCR Profiler Array (SABiosciences, Valencia, CA). Real Time PCR was performed using the CFX96 (BioRad, Hercules, CA)
by  heating to 95 ◦C for 10 min  followed by 40 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min. Data was analyzed using the !!Ct method according to the SABiosciences web
portal  (www.SABiosciences.com/pcrarray.dataanalysis.php) and further recalculated manually. The same threshold value was  used across all plates in the same data analysis
to  ensure accurate reading of quality controls. The data were normalized across all plates to the following housekeeping genes: beta-2-microglobulin (B2M), hypoxanthine
phosphoribosyltransferase 1 (HPRT1), ribosomal protein L13a (RPL13A), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and beta actin (ACTB). Controls for genomic
DNA  contamination RNA quality, and PCR performance were all in the recommended ranges. Data are represented as fold change compared to expression levels in HEK293
cells.  The results are the average of three biological replicates.
results were slightly more variable, with a fold change of 1.97 when
analyzed on the JAK-STAT array but only 1.45 on the GPCR array. For
two genes, JUN and FOS, protein expression was also examined by
Western blot, and a modest increase in jun and fos protein levels
was  detected in both the 293-US27 and 293-US28 cells (Fig. 6),
which further supports findings of the PCR array.
During infection, HCMV can have a striking impact on cell gene
expression and other cellular functions. We  have focused on one
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Fig. 4. JAK-STAT pathway gene expression levels in 293-US27 cells. The fold change values from three biological replicates of the PCR array were analyzed in comparison to
293-CXCR3 cells as a baseline control. Error bars indicate standard error; * indicates genes with a 1.8-fold change or higher.
viral gene, US27, and its effect on cell physiology when expressed
in isolation in human cells. We  found that the presence of the US27
gene product leads to enhanced cell proliferation and DNA synthe-
sis compared to controls. This suggests that like US28 (Maussang
et al., 2006, 2009; Slinger et al., 2010) and ORF74 of KSHV (Kasposi’s
sarcoma associated herpesvirus) (Bais et al., 1998), under certain
conditions, US27 can stimulate cell division and promote enhanced
growth. Evaluation of cellular gene expression using PCR profiler
arrays led to the identification of several host genes that may  play
a role in the enhanced growth rate observed in cells expressing
HCMV US27. The JAK-STAT PCR array was utilized in this study
because US28 has previously been shown to stimulate cell prolif-
eration through induction of IL-6, with downstream signaling by
JAK1 and STAT3 (Slinger et al., 2010). Here, we report that the gene
encoding oncostatin M,  a cytokine that belongs to the IL-6 family
with roles in hematopoiesis and inflammation, is significantly up-
regulated by both US27 and US28. This result is consistent with
transcriptome analyses that found upregulation of oncostatin M
gene expression in HCMV-infected monocytes (Chan et al., 2008a,
2008b). Oncostatin M was also found to be one of the most abun-
dant proteins present in the supernatants of virus-infected cells
(Dumortier et al., 2008) and has been identified as a major growth
factor for Kaposi’s sarcoma spindle cells (Nair et al., 1992).
In addition to oncostatin M,  increased expression of the JUN
and FOS genes was  observed in cells expressing US27. The jun
and fos proteins typically form homo- or heterodimers to com-
prise the transcription factor AP-1, which plays a critical role in
the regulation of multiple genes controlling cell proliferation and
apoptosis (Angel and Karin, 1991). Induction of AP-1 upon infec-
tion with HCMV has been well-documented (Boldogh et al., 1990,
Table 1
JAK-STAT pathwaya gene expression analysis.
Unigene Refseq Symbol Description Fold changeb
US27 US28
Hs.516966 NM 138578 BCL2L1 BCL2-like 1 1.97 −1.43
Hs.709456 NM 000567 CRP C-reactive protein, pentraxin-related 1.36 3.11
Hs.654394 NM 005211 CSF1R Colony stimulating factor 1 receptor 1.63 4.09
Hs.592192 NM 000395 CSF2RB Colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) 1.36 3.11
Hs.77367 NM 002416 CXCL9 Chemokine (C-X-C motif) ligand 9 1.36 3.11
Hs.77424 NM 000566 FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) 1.84 2.61
Hs.518805 NM 002131 HMGA1 High mobility group AT-hook 1 1.43 2.49
Hs.529400 NM 000629 IFNAR1 Interferon (alpha, beta and omega) receptor 1 1.45 2.04
Hs.504035 NM 001558 IL10RA Interleukin 10 receptor, alpha 1.73 2.64
Hs.272373 NM 018724 IL20 Interleukin 20 1.36 3.11
Hs.84  NM 000206 IL2RG Interleukin 2 receptor, gamma  1.17 2.54
Hs.73917 NM 000589 IL4 Interleukin 4 1.55 2.81
Hs.532082 NM 002184 IL6ST Interleukin 6 signal transducer (gp130, oncostatin M receptor) 1.27 1.97
Hs.436061 NM 002198 IRF1 Interferon regulatory factor 1 1.68 2.64
Hs.458485 NM 005101 ISG15 ISG15 ubiquitin-like modifier 1.60 2.23
Hs.714791 NM 002228 JUN Jun proto-oncogene 1.97 1.69
Hs.375129 NM 002422 MMP3  Matrix metallopeptidase 3 (stromelysin 1, progelatinase) −1.01 2.21
Hs.524760 NM 002534 OAS1 2′-5′-Oligoadenylate synthetase 1, 40/46 kDa 1.36 3.11
Hs.248156 NM 020530 OSM Oncostatin M 2.75 2.51
Hs.74615 NM 006206 PDGFRA Platelet-derived growth factor receptor, alpha polypeptide −1.05 −3.45
Hs.654514 NM 002838 PTPRC Protein tyrosine phosphatase, receptor type, C 1.36 3.11
Hs.15744 NM 015503 SH2B1 SH2B adaptor protein 1 1.40 2.06
Hs.713578 NM 175077 SLA2 Src-like-adaptor 2 1.20 2.71
Hs.485572 NM 003877 SOCS2 Suppressor of cytokine signaling 2 1.94 1.45
Hs.527973 NM 003955 SOCS3 Suppressor of cytokine signaling 3 1.55 2.05
Hs.468426 NM 144949 SOCS5 Suppressor of cytokine signaling 5 1.95 1.97
Hs.75516 NM 003331 TYK2 Tyrosine kinase 2 1.82 2.07
a The complete list of genes analyzed on this array is shown in Fig. 3 and includes: A2M, SH2B2, BCL2L1, CCND1, CDKN1A, CEBPB, CRK, CRP, CSF1R, CXF2RB, CXCL9, EGFR,
EPOR,  F2, F2R, FAS, FCER1A, FCGR1A, 1SG15, GATA3, GBP1, GHR, HMGA1, AFNAR1, AFNG, AFNGR1, IL10RA, IL20, IL2RA, IL2RG, IL4, IL4R, IL6ST, INSR, IRF1, ISGF3G, JAK1, JAK2,
JAK3,  JUN, JUNB, MMP3, MPL, MYC, NFKB1, NOS2A, NR3C1, OAS1, OSM, PDGFRA, PIAS1, PIAS2, PPP2R1A, PRLR, PTPN1, PTPRC, SH2B1, SIT1, SLA2, SMAD1, SMAD2, SMAD3,
SMAD4, SMAD5, SOCS1, SOCS2, SOCS3, SOCS4, SOCS5, SP1, SPI1, SRC, STAM, STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, STAT6, STUB1, TYK2, USF1, YY1.
b Gene expression was analyzed using Human JAK-STAT RT2 Profiler PCR Arrays (SABiosciences, Valencia, CA) in triplicate as described in the legend for Fig. 3. Fold change
was  calculated via the comparative threshold cycle method using values for 293-CXCR3 cells as the baseline.
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Fig. 5. GPCR pathway gene expression levels in cells expressing US27, US28, or CXCR3. RNA from each stable cell line was extracted using RNEasy Midi Kit (Qiagen,
Valencia,  CA), cDNA was  prepared using the RT2 First Strand Kit (Qiagen), and then diluted cDNA was  mixed with the RT2 SYBR green master mix  (Qiagen) according to
the  manufacturer’s instructions and loaded into the Human GPCR RT2-PCR Profiler Array (SABiosciences, Valencia, CA). Data analysis was  performed as described for the
JAK-STAT array in the legend for Fig. 3 except that the GPCR results are the average of two biological replicates.
1991), and stimulation of AP-1 activity has previously been linked
to at least two specific viral proteins: IE1 (Kim et al., 1999; Wang and
Sonenshein, 2005) and the tegument protein pp71 (Liu and Stinski,
1992). We  show not only an increase in gene expression for JUN and
FOS, but also an increase in jun and fos protein levels, strongly sup-
porting the notion that US27 may  induce changes in cellular gene
expression through the action of the AP-1 transcription factor.
Cells expressing US27 also exhibited an increase in expression
of the BCL2L1 gene. While there was some variability in the
fold-change of up-regulation detected on the JAK-STAT array
compared to the GPCR array, the overall trend indicated increased
BCL2L1 gene expression. The protein encoded by this gene is also
known as Bcl-x, a member of the Bcl-2 protein family that plays
critical roles in regulation of cell survival (Boise et al., 1993). Bcl-x
is expressed as two  isomeric forms, Bcl-xL and Bcl-xS, which are
typically present in the cytosol in association with the mitochon-
drial membrane. Bcl-xL forms heterodimers with various proteins,
including Bax, Bak and Bcl-2, and prevents cell death by blocking
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Table 2
GPCR pathwaya gene expression analysis.
Unigene Refseq Symbol Description Fold changeb
US27 US28
Hs.99913 NM 000684 ADRB1 Adrenergic, beta-1-, receptor 1.63 −2.22
Hs.728754 NM 031850 AGTR1 Angiotensin II receptor, type 1 −1.09 1.13
Hs.516966 NM 138578 BCL2L1 BCL2-like 1 1.45 −2.03
Hs.470882 NM 005795 CALCRL Calcitonin receptor-like 1.19 5.41
Hs.303649 NM 002982 CCL2 Chemokine (C-C motif) ligand 2 1.44 2.85
Hs.260074 NM 000103 CYP19A1 Cytochrome P450, family 19, subfamily A, polypeptide 1 2.10 4.07
Hs.73893 NM 000795 DRD2 Dopamine receptor D2 1.57 1.42
Hs.728789 NM 005252 FOS FBJ murine osteosarcoma viral oncogene homolog 2.35 1.11
Hs.714791 NM 002228 JUN Jun proto-oncogene 1.84 1.56
Hs.106795 NM 000912 OPRK1 Opioid receptor, kappa 1 1.53 3.49
Hs.32942 NM 002649 PIK3CG Phosphoinositide-3-kinase, catalytic, gamma  polypeptide 1.28 2.33
Hs.196384 NM 000963 PTGS2 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 1.12 2.22
a The complete list of genes analyzed on this array is shown in Fig. 5 and includes: ADCY5, ADORA2A, ADRB1, ADRB2, AGT, AGTR1, AGTR2, AGTRAP, AKT1, ARRB1, ARRB2,
BAI1,  BCL2, BCL2L1, CALCRM CALCRL, CASR, CCL2, CCL4, CCND1, CCNE1, CCNE2, CDKN1A, CDKN1B, CFLAR, COL1A1, CRHR1, CRHR2, CTGF, CYP19A1, DRD1, DRD2, DUSP14,
EDN1,  EGR1, ELK1, ELK4, FGF2, FOS, GALR2, GCGR, GNAQ, GNAS, GRM1, GRM2, GRM4, GRM5, GRM7, ICAM1, IL1B, IL1R1, IL1R2, IL2, JUN, JUNB, LHCGR, LPAR1, LPAR2, MAX,
MMP9, MYC, NOS2, OPRD1, OPRK1, PDPK1, PIK3CG, PRKCA, PTGDR, PTGS2, PTH1R, RGS2, RHO, S1PR1, S1PR2, S1PR3, SCTR, SERPINE1, SOCS1, TNF, TSHR, UCP1, VCAM1,
VEGFA,  YWHAZ.
b Gene expression was analyzed using Human GPCR RT2 Profiler PCR Arrays (SABiosciences, Valencia, CA) in duplicate as described in the legend for Fig. 5. Fold change
was  calculated via the comparative threshold cycle method using values for 293-CXCR3 cells as the baseline.
the formation of channels in the mitochondrial membrane and
inhibiting activation of the caspase cascade (Straten and Andersen,
2010). Overexpression of Bcl-2 family pro-survival genes is a
common mechanism for preventing apoptosis, and cells infected
with HCMV have previously been found to contain elevated levels
of Bcl-2 protein (Cinatl et al., 1998). Although levels of Bcl-x protein
in HCMV-infected cells have not been reported to date, microarray
analysis of infected monocytes revealed a 4.9-fold increase in
the level of BCL2A1 (Bcl-2 related protein A1) mRNA (Chan et al.,
2008a). In fact, Chan et al. found that infection of monocytes led
to the induction of many genes associated with the differentiation
into a macrophage phenotype, with 583 genes significantly up-
regulated and 621 genes significantly downregulated (Chan et al.,
2008a). One of the genes found to be up-regulated in that study
was SOCS3, a suppressor of cytokine signaling. In our study with
HCMV US27 expressed in isolation, no significant changes in SOCS3
expression were noted, but both SOCS2 and SOCS5 were found
to be up-regulated. It is not surprising that HCMV might have
multiple mechanisms for activating SOCS proteins and suppressing
inflammatory cytokines, since this would likely aid the virus in
avoiding immune clearance.
Another global analysis of host cell gene expression during virus
infection utilized the AD169 strain of HCMV compared to a US28-
deletion mutant (Hertel and Mocarski, 2004). The results showed
Fig. 6. Jun and Fos protein levels are higher in cells expressing either US27 or US28.
Stable cell lines expressing either US27, US28 or CXCR3 or control HEK293 cells were
lysed, proteins separated by SDS-PAGE, and then immunoblotted with antibodies
directed against jun, fos, or total MAPK (Santa Cruz Biotechnology, Santa Cruz, CA)
followed by AP-conjugated secondary antibody.
that while numerous changes occur upon infection, only a small
subset of genes involved in cell cycle progression could be specif-
ically attributed to the presence of US28, and none of those were
the same genes identified as being impacted by US28 expression
in this study. Future work will focus on the protein products of the
genes affected by US27, both in transfected and virus-infected cells,
in order to confirm that activity is increased and thus contributing
to US27-mediated enhancement of cell proliferation. These studies
will help clarify the role of US27 in virus infection and could provide
a potential target for novel anti-viral therapeutics.
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HCMV US27 is a viral receptor with similarities to chemokine receptors.  While 
US27 is an orphan receptor, we found that US27 expression results in increased cellular 
proliferation and survival in HEK293 cells.  In this study, we examined the involvement 
of two protein domains, the DRY (aspartic acid, arginine, tyrosine) box and the C-
terminal intracellular domain (CTD) of US27, in mediating both cell proliferation and 
survival.  While both domains were required for a proliferative effect, loss of either 
domain only moderately impacted cell survival, suggesting that US27 may interact with 
cell survival pathways through protein regions other than the DRY box and CTD.  Cells 
expressing US27 had the lowest percentage of apoptotic cells when compared to control 
cells.  Quantitative RT-PCR arrays were used to profile changes in cellular gene 
expression in the HEK293-US27 cell line, and down-regulation of cell cycle regulators 
CDKN1A/p21/CIP1 (cyclin dependent kinase inhibitor 1A) and SESN (Sestrin2 or Hi95) 
was observed.   These results indicate that increased cell proliferation due to US27 may 
be linked to suppression of negative growth regulators, and that these interactions require 
the DRY box and CTD.  !
The DRY Box and C-Terminal Domain of the Human
Cytomegalovirus US27 Gene Product Play a Role in
Promoting Cell Growth and Survival
Carolyn C. Tu, Juliet V. Spencer*
Department of Biology, University of San Francisco, San Francisco, California, United States of America
Abstract
Human cytomegalovirus (HCMV) is a widespread pathogen that can lay dormant in healthy individuals and establish lifelong
latent infection. This successful co-existence is facilitated by a number of viral gene products that manipulate host cellular
functions and immune responses. Among these immunomodulatory genes are four G-protein coupled receptors (GPCRs)
encoded by HCMV, designated US27, US28, UL33, and UL78. Studies have shown the US28 gene product to be a functional
chemokine receptor that signals both constitutively and in a ligand-dependent manner, resulting in a wide range of cellular
effects. In previous work, we have found that US27 expression results in at least two biological effects: enhanced CXCR4
signaling and increased in cellular proliferation in HEK293 cells. Here, we examined the involvement of two protein domains,
the DRY box and the C-terminal intracellular domain (CTD) of US27, in mediating both cell proliferation and survival. While
both domains were required for a proliferative effect, loss of either domain only moderately impacted cell survival,
suggesting that US27 may interact with cell survival pathways through protein regions other than the DRY box and CTD.
Quantitative RT-PCR arrays were used to profile changes in cellular gene expression in the HEK293-US27 cell line, and down-
regulation of cell cycle regulators CDKN1A/p21/CIP1 (cyclin dependent kinase inhibitor 1A) and SESN (Sestrin2 or Hi95) was
observed. These results indicate that increased cell proliferation due to US27 may be linked to suppression of negative
growth regulators, and that these interactions require the DRY box and CTD.
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Introduction
Human cytomegalovirus (HCMV) is a member of the
Herpesviridae family that manipulates the host immune system
and establishes life-long latent infection [1]. HCMV is widespread
in the general population, but infection is typically asymptomatic
in immune competent individuals [2]. Transplant recipients and
HIV patients, on the other hand, can suffer debilitating disease
upon virus reactivation [3,4]. In addition, during pregnancy,
HCMV may be transmitted in utero to the developing fetus,
resulting in severe congenital defects like deafness, blindness,
mental retardation, and impaired motor function [5,6].
Successful co-existence of HCMV with a healthy host is
mediated to some extent by the production of viral proteins that
mimic normal immune modulators like cytokines, chemokines,
and chemokine receptors [7]. The US27 gene encodes a protein
with seven transmembrane domains and similarity to the human
chemokine receptor family of G-protein coupled receptors
(GPCRs), including conserved cysteines in the extracellular loops
and extensive glycosylation of the extracellular domain [8]. US27
also contains a DRY (aspartic acid, arginine, tyrosine) motif in the
second intracellular loop that is critical in other GPCRs for
activation of G proteins following ligand binding [9], as well as a
di-leucine motif in the carboxy-terminal domain that mediates
receptor endocytosis [10]. US27 is found in the envelope of the
virus particle [8], but in virus-infected cells, the majority of the
US27 protein is found in endosomes, the Golgi apparatus, and
perinuclear compartments [11]. The US27 gene is non-essential
for virus replication and mutants that lack US27 are replication
competent [12]. However, US27 deletion mutant viruses are
incapable of spreading via the extracellular route in endothelial
cells [13], suggesting that US27 might play a role in virion
assembly or egress.
Although no chemokine ligands for US27 have been identified,
signaling activity of the human chemokine receptor CXCR4 is
increased in the presence of US27 [14]. In addition, cells
expressing US27 demonstrate increased rates of cell proliferation
and DNA synthesis [15]. Here, we further investigated the
mechanism for this proliferative effect by examining the require-
ment for the DRY box motif and the carboxy-terminal domain
(CTD) of US27 in cell growth and resistance to apoptotic stimuli.
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Materials and Methods
Cells
Human embryonic kidney (HEK) 293 cells were grown in
Eagle’s minimal essential media (MEM) with 10% fetal bovine
serum (Cellgro, Herndon, VA) in a humidified incubator at 37uC
and 5% CO2 atmosphere. Stable HEK293 cell lines expressing
3XFLAG-tagged HCMV US27, US28, or human CXCR3 were
generated previously and cultivated under the same conditions
[10]. In addition, stable cell lines expressing 3XFLAG-tagged
US27-DAY (R128A) and US27/XR3CT were also cultured as
above [14].
HEK293 or HeLa cells were maintained as above, then seeded
in white 96-well plates at a density of 16104 cells per well and
transiently transfected 24 hours later with the indicated pEGFP
expression vectors using Fugene transfection reagent (Roche
Biosciences, Basel, Switzerland) at a ratio of 3:1 (ml Fugene: mg
plasmid DNA per manufacturer’s instructions). Transfection
efficiency was 40–50% as determined via flow cytometry.
Western Blotting
Cells were seeded into 100 mm dishes at a density of 86105
cells and lysed in the dish after 48 hours via the addition of lysis
buffer (150 mM NaCl, 20 mM HEPES, 0.5% Cymal-5, 1 mM
NaOV4, 1 mM EDTA, 0.1% NaN3 and 4 M urea). The lysate
was freeze-thawed three times, clarified via centrifugation at
14,000 rpm for 15 minutes at 4uC, followed by addition of loading
dye. Samples were separated using SDS-PAGE, and then proteins
were transferred to a nitrocellulose filter then blocked in Tris-
buffered saline containing 0.1% Tween-20 (TBS-T) +5% milk for
one hour. The membranes were incubated with either anti-p21
monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz,
CA), anti-sestrin or anti-MAPK rabbit polyclonal antiserum (Cell
Signaling Technology, Danvers, MA) as indicated according to the
manufacturer’s instructions. For anti-FLAG M2 western blotting,
cells were seeded as indicated above and scraped 48 hours later in
cold RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1%
NP-40, 1% sodium deoxycholate, 0.1% SDS), followed by PBS
wash, and resuspension of pellet with 100 ml of cold RIPA buffer.
Cell lysates were agitated every 15 minutes for one hour,
sonicated, and centrifuged at 14,000 rpm at 4uC for 15 minutes.
Clarified cell lysates were then transferred into eppendorf tubes.
After the addition of 46 Laemmli buffer (Bio-Rad) and 106
sample reducing agent (Life Technologies), cell lysates were heated
at 42uC for 10 minutes. Samples were then separated using SDS-
PAGE and transferred onto a nitrocellulose membrane as
described above, followed by overnight incubation at 4uC with
anti-FLAG M2 monoclonal antibody (Sigma Aldrich, St. Louis,
MO) at a 1:7500 dilution. For detection, membrane was incubated
with appropriate alkaline phosphatase-conjugated secondary
antibody. Bands were visualized via the addition of Western Blue
Substrate reagent (Promega, Madison, WI).
Immunofluorescence Microscopy
HEK293 and stable cells were seeded in six-well dishes
containing FBS coated glass coverslips at a density of 1.56105
cells per well and then incubated for 48 hours at 37uC. Cell
monolayers were washed with PBS, fixed with 4% paraformalde-
hyde, then permeabilized with 0.2% (w/v) Triton X-100. Cells
were then blocked with PBS +10% FBS for one hour at 37uC and
stained with anti-FLAG M2 antibody (Sigma-Aldrich) at a 1:1000
dilution for one hour at 37uC. Following three PBS washes, the
coverslips were incubated with Alexa Fluor 514 Goat Anti-Mouse
(Life Technologies) at a 1:500 dilution for one hour at 37uC,
washed again, and then mounted on a glass slide using Prolong
Gold anti-fade reagent with DAPI (Invitrogen, Carlsbad, CA). For
cell surface receptor staining only, the protocol was followed as
described above but cells were not permeabilized. All images were
acquired using a Zeiss LSM700 laser scanning confocal fluores-
cence microscope and Zen Black software (Carl Zeiss, Inc.,
Oberkochen, Germany).
Proliferation Assays
Cells were seeded in white 96-well dishes at a density of 56103
cells per well. Cell growth was measured at indicated time points
via the addition of CellTiter-Glo reagent (Promega) followed by
luminometry according to manufacturer’s instructions. Bromode-
oxyuridine (BrdU) incorporation was assayed on cells seeded as
above using the BrdU ELISA kit (Roche Bioscience, South San
Francisco, CA). For both assays, each condition was performed in
triplicate within the assay, and three independent replicates of
each experiment were performed. For cell counts, cells were
seeded into 6-well dishes at 26105 cells per well, harvested via
trypsinization at the indicated times, and then 3610 ml aliquots
were analyzed from each well at the indicated times using the BD
Accuri C6 Flow Cytometer (Becton Dickinson, San Jose, CA).
Three independent experiments assessing cell counts were
performed.
Apoptosis Assays
Cells were seeded into 6-well dishes and treated with 10 mM
etoposide (Sigma-Aldrich) for 48 hours, then harvested and
stained with Annexin V and propidium iodide using the TACS
Annexin V-FITC Staining Kit (Trevigen, Gaithersburg, MD)
before analysis by flow cytometry. In addition, cells were seeded
into white 96 well plates at a density of 56103 cells per well in the
presence of 10 mM etoposide, and cell viability determined at
indicated time points via the addition of CellTiter-Glo reagent as
above. For transiently transfected HEK293 and HeLa cells,
10 mM etoposide was added six hours post-transfection. In all
cases, each condition was performed in triplicate within the assay,
and three independent experiments were performed.
PCR
RNA from HEK293 or stable cell lines that were 70–80%
confluent in a T75 flask was extracted using RNEasy Midi Kit
(Qiagen, Valencia, CA), cDNA was prepared using the RT2 First
Strand Kit (Qiagen), and then diluted cDNA was mixed with the
RT2 SYBR green master mix (Qiagen) according to the
manufacturer’s instructions and loaded into the Human p53
Signaling Pathway RT2-PCR Profiler Array (SABiosciences,
Valencia, CA). Real-Time PCR was performed using the
CFX96 (BioRad, Hercules, CA) by heating to 95uC for 10 minutes
followed by 40 cycles of 95uC for 15 seconds and 60uC for
1 minute. Data were analyzed using the DDCt method according
to the SABiosciences web portal (www.SABiosciences.com/
pcrarray.dataanalysis.php) as described previously [15] and are
provided as Supplementary Data. The same threshold value was
used across all plates in the same data analysis to ensure accurate
reading of quality controls. The data were normalized across all
plates to the following housekeeping genes: beta-2-microglobulin
(B2M), hypoxanthine phosphoribosyltransferase 1 (HPRT1),
ribosomal protein L13a (RPL13A), glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), and beta actin (ACTB). Controls for
genomic DNA contamination, RNA quality, and PCR perfor-
mance were all in the manufacturer’s recommended ranges. The
fold change values from three biological replicates of the PCR
array were analyzed in comparison to either HEK293 cells or 293-
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CXCR3 cells as indicated. For RT-PCR, RNA from HEK293 or
stable cell lines was extracted using RNeasy Midi Kit (Qiagen,
Valencia, CA). cDNA was prepared using the iscript cDNA
synthesis kit (Bio-Rad). For PCR reactions, each contained cDNA
template, primers, dNTP mix, Ex-Taq buffer, and Ex-Taq
polymerase (Clontech, Mountain View, California) in a final
volume of 30 ml. The gene specific primers for Sestrin-2 were 59 –
CCTGCACCCTGACTACTTTAC – 39 (forward) and 59 –
CCATGGTCTTCCCAGGTATAATC – 39 (reverse) and for b-
actin specific primers, 59 – AAGAGAGGCATCCTCACC – 39
(forward) and 59 – TACATGGCTGGGTGTTG – 39 (reverse).
The PCR reaction underwent the following protocol on a
MyCycler Thermal Cycler (Bio-Rad): 95uC for 1 min followed
by 35 cycles of 94uC for 1 min, 55uC for 1 min, 72uC for 1 min,
followed by one cycle of 72uC for 10 min, and a final hold at 4uC.
The PCR products were visualized on a 1% agarose gel.
Results and Discussion
The US27 gene product has been shown to promote an increase
in cell proliferation when compared to cells expressing US28 or
other cellular chemokine receptors like CXCR3 [15]. Here, we
investigated whether specific domains of US27 are necessary to
mediate this proliferative effect by making use of two mutants
available in our laboratory. First, we examined the requirement
for the DRY box motif that is known to play a role in signaling for
many GPCRs [9] by using a stable HEK293 cell line expressing
US27-DAY, which contains a single amino acid substitution of
arginine 128 to alanine (R128A). We also explored the require-
ment for the intracellular carboxy-terminal domain (CTD) using
both a stable HEK293 cell line expressing US27/XR3CT, a
chimeric receptor that has the CTD of CXCR3 in place of the
CTD from US27, as described previously [10], and a mutant
lacking the CTD, US27DCT. As shown in Figure 1, wild-type
US27 and the US27 mutants were expressed at comparable levels.
Cell lysates were immunoblotted with antibody directed against
the N-terminal 3XFLAG tag, and the expected broad band of 45–
50 kD for the US27 protein, which is heavily glycosylated, was
detected (Fig. 1A). Comparable bands were noted for both the
US27-DAY and US27/XR3CT receptors, demonstrating that
these changes do not adversely affect protein expression. US28
and CXCR3, an HCMV and a human chemokine receptor,
respectively, serve as controls in several subsequent experiments
and were also detected at the expected sizes of 44 kD and 42 kD.
No 3XFLAG labeled proteins were detected in the parent
HEK293 cell line. Each receptor was also viewed by immunoflu-
orescence microscopy, and the expression level for the US27-DAY
and US27/XR3CT proteins was similar to that of wild-type
US27, US28, and CXCR3 (Fig. 1B). To confirm that the
mutations in US27 did not alter receptor trafficking to the surface,
cells were fixed but not permeabilized, then incubated with anti-
FLAG antibody. As shown in Fig. 1C, the level of staining was
comparable between US27 and the mutants, indicating that these
receptors are present on the cell surface and that the mutations in
US27 have no effect on receptor recycling.
In order to examine the impact of these mutations on the ability
of US27 to enhance cell proliferation, growth of the stable cell
lines was monitored over time. Cell viability was evaluated using a
substrate for total cellular ATP, reflecting the number of
metabolically active cells in the well (Fig. 2A). Cells expressing
wild-type US27 exhibited ATP levels that were higher than any of
the other cell lines, which included the parent HEK293 cells, cells
expressing US28, CXCR3, or the US27 mutants. Cells expressing
US27-DAY and US27/XR3CT were healthy and exhibited
growth, but the ATP levels were more similar to control cells
than US27-expressing cells. There was no evidence that either
mutation resulted in a protein that facilitated the same growth
advantage as wild-type US27.
Cells expressing US27 mutants were further investigated using
BrdU incorporation to determine whether there was any effect on
the rate of DNA synthesis (Fig. 2B). While cells expressing wild-
type US27 exhibited a marked increase in the rate of DNA
synthesis relative to control cells, the US27-DAY and US27/
XR3CT cell lines had a rate of DNA synthesis that was on par
with the control cells. In addition, standard cell counts confirmed
that only US27-expressing cells, and not the US27 mutant-
expressing cell lines, contained higher cell numbers than controls
when counted at the indicated times (Fig. 2C). While we have
previously shown that US27 conveys increased proliferative
properties in a variety of cell types [15], we wanted to examine
the US27 mutants in a different cell type. Both HEK293 and
HeLa cells were transiently transfected using EFGP-tagged US27,
US27-DAY, or US27DCT constructs, and cell growth monitored
(Fig. 2D, E). In both cell types, US27 cells grew at a significantly
higher rate than cells expressing either mutant receptor or the
controls. These results suggest that both the DRY box and the
CTD of US27 may be required for stimulating cell proliferation.
Next we investigated whether US27 could protect cells from
apoptosis. Cells were treated with etoposide to block topoisomer-
ase function, thereby impeding DNA replication and leading to
induction of the apoptotic cascade, which was detected via flow
cytometry with Annexin V and propidium iodide staining. As
shown in Figure 3A, cells expressing US27 had the lowest levels of
apoptosis, with only 4.9% of the population staining double
positive (DP) for Annexin V and propidium iodide after 48 hours.
In contrast there were 15.3% DP cells in the US28 cell cultures,
which is not surprising since this receptor has been reported to
induce apoptosis when expressed in a variety of cell types [16].
Cultures expressing US27-DAY had 6.2% DP, which was
comparable to the control HEK293 cell line (6.9%), and the
US27/XR3CT cultures had 7.3% DP cells. Overall, US27-
expressing cells had the lowest rate of etoposide-induced apoptosis
(Fig. 3B), while cells expressing the US27 mutants responded more
like the control cells, indicating that the DRY box and CTD may
help mediate cell survival.
When cell viability was monitored over time, US27-expressing
cells exhibited significantly greater viability than the other cells
types (Fig 3C). Surprisingly, US27/XR3CT cells also had greater
viability than most other cultures from 48 to 96 hours. The
viability of cells expressing US27/XR3CT was significantly higher
than US28 or control HEK293 cells, but significantly lower than
US27-expressing cells, suggesting that this mutant may still be able
to either partially block apoptosis or stimulate survival pathways,
conferring a moderately protective effect. While US28 cells
exhibited the highest levels of apoptosis at 48 hrs (Fig. 3A), the
death rate in these cultures at later time points was significantly
lower than in control HEK293 or CXCR3-expressing cells
(Fig. 3B). The overall viability in the US27-DAY cultures was
almost identical to that of US28 and also significantly lower than
in control cells, indicating that this mutant might also retain some
ability to protect cells from programmed cell death. Thus, unlike
the proliferative ability of US27, which was completely abrogated
by mutation of the DRY box and CTD, the ability to protect from
etoposide-induced death was only partially diminished by these
mutations. Given that the protection was less evident at the earliest
time points, it may be that mutations delayed the activation of
survival pathways by US27, but ultimately the US27-DAY and
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Figure 1. Stable cell lines express HCMV US27 or US27 mutants. A) Cell lysates were separated by SDS-PAGE and then immunoblotted using
anti-FLAG M2 antibody or anti-MAPK as a control. (B) Immunofluorescence staining of fixed, permeabilized cells with anti-FLAG M2 antibody followed
by Alexa Fluor 514-conjugated mouse secondary. Optical sectioning was performed and one slice of the Z-stack is shown. (C) Cell surface staining
with anti-FLAG M2 antibody on non-permeabilized cells, followed by Alexa Fluor 514 secondary antibody.
doi:10.1371/journal.pone.0113427.g001
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Figure 2. Expression of US27 conveys a proliferative advantage. A) Cells were seeded into 96-well plates at a density of 56103 cells per well
and cell number was monitored via the addition of CellTiter-Glo reagent at the indicated time points. B) The rate of DNA synthesis for each cell line
was measured using bromodeoxyuridine (BrdU) incorporation and luminometry. C) Cells were seeded in 6-well dishes at 26105 cells per well, then
harvested with trypsin and counted via flow cytometry at the indicated time points. (D) HEK293 and (E) HeLa cells were seeded into 96-well plates at
a density of 16104 cells per well and transfected 24 hours later with the indicated pEGFP expression vector at a ratio of 3:1 (ml Fugene: mg plasmid
DNA), cell number was monitored via the addition of CellTiter-Glo reagent at the indicated time points. Error bars represent standard error of three
triplicate data points within one experiment. These results are representative of three independent experiments. ** indicates p,0.001, * indicates p,
0.05 by Student t-test.
doi:10.1371/journal.pone.0113427.g002
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Figure 3. HEK293 cells expressing wild type US27 are more resistant to apoptosis. Cells were treated with 10 mM etoposide to induce
apoptosis. A) After 48 hours, cells were stained with propidium iodide and Annexin V then analyzed by flow cytometry. B) The average percent
positive cells for Annexin V, propidium iodide (PI) or both (double positive, DP) from three independent experiments, as indicated in A above. *
indicates p,0.01 by Student t-test compared to US27-cells. Overall cell viability was measured at the indicated time points via the addition of
CellTiter-Glo reagent and total luminescence quantified in C) stable HEK293 cell lines, and in transiently transfected D) HEK293 cells and E) HeLa cells
following etoposide treatment. Error bars represent standard error of three triplicate data points within one experiment. These results are
representative of three independent experiments. ** indicates p,0.001, * indicates p,0.05 by Student t-test. In C, pairwise comparisons were
performed between US27/XR3CT and US27, US28, and HEK293 and between US27-DAY and US27 and HEK293.
doi:10.1371/journal.pone.0113427.g003
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US27/XR3CT proteins were still able to convey anti-apoptotic
effects to the cell.
In order to further explore the effect of the US27, US27-DAY,
and US27/XR3CT on cell survival, quantitative PCR array
analysis was performed on the stable cell lines. RNA was extracted
from each cell type and expression levels of 84 genes involved in
the p53 signaling pathway were compared to the parent HEK293
cells. As shown in Table 1, only a small subset of genes exhibited a
fold change of 1.5 or higher that was statistically significant. Some
genes were found to be down-regulated in all five cell lines stably
expressing viral or human GPCRs, like CDKN1A, or p21, the
cyclin-dependent kinase inhibitor. Although cells expressing US27
had the greatest fold change decrease (22.41), the overall trend
was that CXCR3, US28, and the US27 mutants all caused down-
regulation of CDKN1A, suggesting that overexpression of any
GPCRs might affect the p21 gene. Other genes, like BTG2 and
BAI1, were specifically down-regulated in cells expressing the viral
GPCRs but not in cells expressing CXCR3. For BTG2, (also
known as NGF-inducible anti-proliferative protein PC3 or NGF-
inducible protein TIS21), which is a p53-induced transcriptional
co-regulator of cell cycle progression [17], cells expressing US27
exhibited a 22.05-fold change compared the control HEK293
cells, while cells with the US27-DAY mutant had only a 21.47-
fold change and cells expressing US27/XR3CT had a modest
1.17-fold decrease in expression. This suggests that US27 impacts
the expression of BTG2 and that this effect is mediated to some
extent by the DRY box and to an even greater extent by the CTD
of US27, which may interact with intracellular signaling proteins.
For BAI1, brain-specific angiogenesis inhibitor 1, in the adhesion
GPCR family that is regulated by p53 [18], the opposite effect was
observed. Cells expressing US27 were found to have a 23.47 fold
decrease in expression, compared to 21.02 for US27-DAY and 2
2.03 for US27/XR3CT, suggesting that the DRY box is critical
for down-regulation of BAI1 by US27, while the CTD may play a
less significant role in mediating that effect.
For some genes, the changes in gene expression conveyed by
any of the viral GPCRs were quite distinct from that of the human
GPCR CXCR3. Thus, the fold changes were also calculated using
the values from 293-CXCR3 cells as a baseline (Table 2). As
shown in Figure 4A, both EGR1 and SESN2 were significantly
down-regulated for all four viral GPCR. For SESN2, this pattern
was also evident at a range of time points of cell cultivation
(24 hours, Fig 4B), and at the protein level. Western blotting
revealed decreased levels of Sestrin-2 (also known as Hi95) in cell
lysates expressing US27 and US27-DAY compared to parent
HEK293 or CXCR3-expressing cells (Fig. 4C), although for
US27/XR3CT, the changes in RNA level did not correlate as
clearly with protein level. Sestrin-2 has been identified as a stress
sensor that functions in a p53-independent manner, possibly
through the PI3K/Akt signaling pathway [19,20]. Although
Sestrin-2 is generally considered a pro-survival factor, our results
suggest that the protein is down-regulated by US27, indicating
that the signaling pathways involved may be complex and multi-
functional.
Figure 4. HCMV US27 correlates with decreased expression of p21 and Sestrin-2. A) Fold changes in gene expression compared to levels
in cells expressing CXCR3. B) RNA was harvested from each stable cell line, reverse transcribed, then gene specific primers were used to amplify either
Sestrin-2 or b-actin. C) Cell lysates were separated by SDS-PAGE and immunoblotted with antibodies directed against p21, sestrin-2, or MAPK as
indicated.
doi:10.1371/journal.pone.0113427.g004
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For CDKN1A, a slightly different picture emerged when using
CXCR3 expressing cells as a baseline, compared to the parent
HEK293 cells. While all cell lines showed some level of down-
regulation compared to HEK293 cells, US28 was virtually
identical to CXCR3 (1.04-fold change). In contrast, US27 cells
exhibited a nearly 2-fold down-regulation of CDKN1A, which was
nearly ablated in cells expressing either US27-DAY or US27/
XR3CT. This decrease in gene expression correlated to a modest
reduction in p21 protein levels compared to HEK293, US28, or
CXCR3 cells (Fig. 4C). Since p21 is a negative regulator of cell
cycle progression [21,22], down-regulation of this protein by US27
supports our observations that the US27 protein conveys a
proliferative and survival advantage. Further analysis of the
possible interaction between US27 and the p21 signaling pathway
may provide valuable insights into the mechanistic basis for this
proliferative effect.
Some changes were notable because of a significant impact by
only one of the GPCR examined. Cells expressing US28 had a
dramatic increase in TNF (tumor necrosis factor) expression (4.41
fold) compared to the other cells lines. IFNB1, (interferon-b) was
found to be up-regulated by 2-fold in cells expressing the US27/
XR3CT mutant, but not by US27 or US27-DAY. However, these
changes could not be confirmed at the protein level, and no TNF
or IFNB1 was detected in the supernatants of any of the cell lines
by ELISA (data not shown).
Another interesting change was the significant increase in
expression of ESR1, the estrogen receptor, in cells expressing either
the US27-DAY (3.02-fold change) or US27/XR3CT mutant (5.18
fold change), whereas expression was down-regulated in cells
expressing either US27, US28, or CXCR3. In contrast, the WT1
(Wilms tumor) gene, a tumor suppressor implicated in childhood
nephroblastoma [23,24], was significantly down-regulated in cells
with US27-DAY (24.49-fold) with little impact from wild type
US27 or US27/XR3CT, suggesting that there may be negative
regulation of WT1 that is blocked by US27 and mediated through
signaling involving the DRY box. Although US28 has previously
been implicated in tumorigenesis [25,26], future studies will be
necessary to determine whether the US27 gene might play a role in
tumor formation in either breast, kidney, or other forms of cancer.
In summary, we have shown that expression of HCMV US27
can promote cell proliferation, and that this effect requires both
the DRY box motif and the carboxy terminal intracellular domain
(CTD). While US27 has not yet been associated with any
constitutive signaling pathway [27], our findings suggest that the
viral receptor does likely associate with intracellular signaling
proteins, such as p21 or Sestrin-2, and that the DRY box and
CTD are important for these interactions. The requirement for
the DRY box and CTD was less clear in protection from apoptotic
stimuli, where the protective effect of US27 was diminished, but
not completely abrogated, by the loss of either domain. Additional
work is needed to fully understand the functions and signaling
capabilities of this viral receptor, including whether these
proliferative and pro-survival effects might play a possible role in
tumorigenesis.
Supporting Information
Table S1 Gene expression analysis of US27 compared
to HEK293. RNA was extracted and expression levels of 84
genes involved in the p53 signaling pathway were analyzed using
the p53 RT2 Profiler PCR Array. Raw data and analysis for three
biological replicates of 293-US27 cells compared to values for the
parent HEK293 cells is shown in this supplementary table.
(XLS)
Table S2 Gene expression analysis of US27-DAY com-
pared to HEK293. RNA was extracted and expression levels of
84 genes involved in the p53 signaling pathway were analyzed
using the p53 RT2 Profiler PCR Array. Raw data and analysis for
three biological replicates of 293-US27-DAY cells compared to
values for the parent HEK293 cells is shown in this supplementary
table.
(XLS)
Table S3 Gene expression analysis of US27/XR3CT
compared to HEK293. RNA was extracted and expression
levels of 84 genes involved in the p53 signaling pathway were
analyzed using the p53 RT2 Profiler PCR Array. Raw data and
analysis for three biological replicates of 293-US27/XR3CT cells
compared to values for the parent HEK293 cells is shown in this
supplementary table.
(XLS)
Table S4 Gene expression analysis of US28 compared
to HEK293. RNA was extracted and expression levels of 84
genes involved in the p53 signaling pathway were analyzed using
the p53 RT2 Profiler PCR Array. Raw data and analysis for three
biological replicates of 293-US28 cells compared to values for the
parent HEK293 cells is shown in this supplementary table.
(XLS)
Table S5 Gene expression analysis of CXCR3 com-
pared to HEK293. RNA was extracted and expression levels of
84 genes involved in the p53 signaling pathway were analyzed
using the p53 RT2 Profiler PCR Array. Raw data and analysis for
three biological replicates of 293-CXCR3 cells compared to values
for the parent HEK293 cells is shown in this supplementary table.
(XLS)
Table S6 Gene expression analysis of US27 compared
to CXCR3. RNA was extracted and expression levels of 84 genes
involved in the p53 signaling pathway were analyzed using the p53
RT2 Profiler PCR Array. Raw data and analysis for three
biological replicates of 293-US27 cells compared to values for the
293-CXCR3 cells is shown in this supplementary table.
(XLS)
Table S7 Gene expression analysis of US27-DAY com-
pared to CXCR3. RNA was extracted and expression levels of
84 genes involved in the p53 signaling pathway were analyzed
using the p53 RT2 Profiler PCR Array. Raw data and analysis for
three biological replicates of 293-US27-DAY cells compared to
values for the 293-CXCR3 cells is shown in this supplementary
table.
(XLS)
Table S8 Gene expression analysis of US27/XR3CT
compared to CXCR3. RNA was extracted and expression
levels of 84 genes involved in the p53 signaling pathway were
analyzed using the p53 RT2 Profiler PCR Array. Raw data and
analysis for three biological replicates of 293-US27/XR3CT cells
compared to values for the 293-CXCR3 cells is shown in this
supplementary table.
(XLS)
Table S9 Gene expression analysis of US28 compared
to CXCR3. RNA was extracted and expression levels of 84 genes
involved in the p53 signaling pathway were analyzed using the p53
RT2 Profiler PCR Array. Raw data and analysis for three
biological replicates of 293-US28 cells compared to values for the
293-CXCR3 cells is shown in this supplementary table.
(XLS)
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Chapter 3 Introduction to manuscript in preparation  
 
While no chemokine ligands for US27 have been identified, US27 has been 
shown to be the first viral receptor to enhance the signaling activity of the human 
chemokine receptor CXCR4 [38].  Here, we found that US27 can synergize with cmvIL-
10, an ortholog of human IL-10, to enhance CXCR4 calcium signaling in response to 
CXCL12 more than either viral protein alone.  In HCMV-infected and US27-transfected 
HEK293 cells, exposure to cmvIL-10 significantly increased calcium and migration 
responses to CXCL12, suggesting that the two viral proteins work synergistically to 
enhance CXCR4 signaling.  This cooperative effect may enable HCMV to manipulate 
CXCR4 to alter host immune responses and modify cell trafficking patterns.   
 Furthermore, we also confirmed that the IL-10 receptor and STAT3 activation are 
required for the cmvIL-10-mediated enhancement of CXCR4 activity.  These results 
suggest that HCMV exhibits two distinct mechanisms in potentiating CXCR4 signaling.  
US27 and CXCR4 can be possibly forming heterodimers, while there also might be some 
receptor crosstalk through the IL-10R involving STAT3.  Among many of the roles 
CXCR4 exhibits, one major role is that it can direct HCMV-infected cells to the bone 
marrow, which is a primary site of HCMV latency.  Consequently, a new round of 
infection can be initiated and expand the reservoir of latently infected cells.   
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Abstract 
 
Human cytomegalovirus (HCMV) is a herpesvirus that establishes lifelong latent 
infection.   Successful persistence of HCMV in healthy individuals is characterized by 
extensive manipulation of host cellular functions and immune responses.  The UL111A 
gene encodes cmvIL-10, a homolog of human interleukin-10 (hIL-10), a multi-functional 
cytokine with potent immunosuppressive properties.  Despite having only 27% sequence 
identity to hIL-10, cmvIL-10 retains most functions of hIL-10 and acts by binding and 
signaling through the hIL-10 receptor complex (IL-10R).   Recently hIL-10 was found to 
potentiate the signaling activity of CXCR4, a human chemokine receptor that promotes 
migration of immune cells toward sites of injury or infection and also plays key roles in 
hematopoiesis and immune homeostasis.  We found that cmvIL-10 can also enhance 
signaling of CXCR4 in response to its natural ligand, CXCL12.  HEK293 cells 
endogenously express both CXCR4 and IL-10R, and these cells exhibited significantly 
increased calcium mobilization and migration in response to CXCL12 in the presence of 
cmvIL-10.  Treatment with a STAT3 inhibitor or siRNA blocked the enhanced calcium 
flux, indicating that STAT3 activation is required for potentiation of CXCR4 by cmvIL-
10.  These findings demonstrate that cmvIL-10 triggers events that augment the signaling 
activity of a cellular chemokine receptor, most likely through receptor crosstalk.  We 
have previously reported that HCMV US27, an orphan chemokine receptor, is the first 
viral receptor known to enhance CXCR4 signaling.  Here, we found that cmvIL-10 and 
US27 together enhanced CXCR4 calcium signaling in response to CXCL12 more than 
either viral protein alone.  In US27-transfected HEK293 cells and in virus infected cells, 
exposure to cmvIL-10 was still able to increase calcium and migration responses to 
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CXCL12, suggesting that the two viral proteins work synergistically to enhance CXCR4 
signaling.   This cooperative effect may enable HCMV to manipulate CXCR4 to alter 
host immune responses and modify cell trafficking patterns.  
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Introduction 
 
 
Human cytomegalovirus (HCMV) is a member of the herpesvirus family that is 
widespread in the general population [60].  Seroprevalence ranges from 45-100%  
worldwide [2], and while infection is generally asymptomatic, life-threatening disease 
can occur in immune-compromised hosts, particularly transplant recipients [3] [4].   
HCMV is the most common infectious cause of congenital defects in the United States, 
including deafness, blindness, and debilitating neurological conditions [6]. 
 
Following primary infection, HCMV establishes lifelong latency [11].  Latent infection is 
characterized by a quiescent state in which no virus particles are produced, punctuated by 
periods of reactivation and virus replication.  Transmission occurs due to shedding of 
infectious virus in body fluids such as urine, blood, and saliva  [12].   HCMV is highly 
adapted for successful coexistence with humans through an arsenal of mechanisms for 
manipulation of host immune responses, particularly host cytokine and chemokine 
signaling pathways.    HCMV encodes one functional cytokine (UL111A), one functional 
chemokine (UL146), one receptor with similarity to TNF family receptors (UL144), and 
four putative chemokine receptors (US27, US28, UL33, and UL78) [61]. 
 
The UL111A gene encodes a viral ortholog of human interleukin 10 (hIL-10).  The viral 
cytokine, known as cmvIL-10, has only 27% sequence identity to hIL-10, but binds with 
high affinity to the cellular IL-10 receptor (IL-10R) [55, 62].  Engagement of IL-10R by 
cmvIL-10 dimers results in activation of the Jak/Stat3 signaling cascade to produce 
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immune suppressive effects, including inhibition of inflammatory cytokine synthesis, 
down-regulation of MHC class I and class II, and impaired dendritic cell maturation [56, 
63, 64].    The UL111A gene is expressed during both lytic and latent infection, and these 
immune suppressive effects likely play a critical role in facilitating virus persistence.   
However, not all functions of cmvIL-10 are immune suppressive.  While Th1 type 
immune responses are inhibited, Th2 type responses are promoted by both hIL-10 and 
cmvIL-10, including B cell survival and proliferation [65-67].  Maintenance of the 
peritoneal B cell compartment requires hIL-10, which stimulates proliferation and 
chemotaxis of B lymphocytes by enhancing signaling through CXCR4 [54].   
 
CXCR4 is a human chemokine receptor that plays critical roles in development, 
hematopoiesis, and immune cell trafficking [40].  A member of the G protein-coupled 
receptor (GPCR) superfamily, CXCR4 induces calcium mobilization and chemotaxis 
upon binding of its ligand CXCL12 (also known as stromal derived factor, or SDF-1).  
CXCR4 activity is regulated in a number of ways, including formation of homodimers 
and heterodimers with other cellular and viral GPCRs, including CCR2 [49], CXCR7 
[50], Epstein-Barr Virus BILF1 [51], and HCMV UL33 and UL78 [52].  While these 
interactions tend to inhibit CXCL12-CXCR4 signaling, HCMV US27 was found to 
interact with CXCR4 and enhance CXCL12-induced calcium flux and chemotaxis [38].  
CXCR4 signaling can also be increased by other the actions of other cellular proteins, 
including the T cell receptor [53], and, as described above, hIL-10 [54].    Here, we 
investigated whether cmvIL-10 could also potentiate CXCR4 signaling.  Our results show 
that cmvIL-10 enhances CXCL12-induced CXCR4 signaling outcomes, and also that 
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US27 and cmvIL-10 together have additive effects to increase CXCL12-CXCR4 
signaling.   Thus, HCMV has developed two distinct mechanisms for enhancing CXCR4 
signaling, which may enable the virus to alter host cell trafficking patterns.    
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Results 
 
 
cmvIL-10 enhances calcium mobilization by CXCR4 in response to CXCL12 
To determine whether cmvIL-10 could potentiate the signaling activity of CXCR4, 
HEK293 cells were loaded with a calcium indicator dye, and then stimulated with 
CXCL12.  Chemokine binding induced the release of sequestered calcium ions into the 
cytosol, causing a rapid and transient increase in fluorescence, as shown in Figure 3.1 A.  
When cells were treated with CXCL12 in the presence of cmvIL-10, there was increased 
calcium mobilization, and the peak fluorescence intensity was significantly higher.  The 
viral cytokine alone did not induce calcium mobilization (Figure 1 A, B).  When the 
CXCL12 concentration was fixed at 100 ng/ml, the magnitude of the calcium response 
increased as the dose of cmvIL-10 increased (Figure 1 B).  In addition, cmvIL-10 was 
effective at increasing calcium flux to range of doses of CXCL12 (Figure 1 C).   These 
results demonstrate that the UL111A gene product, cmvIL-10, amplifies CXCR4-
mediated calcium signaling in a dose dependent manner. 
 
cmvIL-10 augments chemotaxis towards CXCL12 
In order to investigate whether cmvIL-10 could enhance downstream signaling outcomes 
of CXCR4, transwell migration assays were performed.  HEK293 cells were placed in the 
upper chamber, separated from the lower chamber containing CXCL12 by a 5.0 µm filter.  
After four and a half hours, cells that traversed the filter were collected and quantified.  
The classic bell-shaped curve for chemotaxis was observed, with maximal migration 
toward 0.1 ng/ml CXCL12 and less cell movement at higher and lower doses (Figure 1 
D).   While the basal movement of cells was comparable in the presence or absence of 
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cmvIL-10, migration toward CXCL12 was significantly increased in the presence of 
cmvIL-10.  Although the dose of CXCL12 eliciting maximal chemotaxis remained 
unchanged, the number of migrating cells increased when cmvIL-10 was included in the 
lower chamber.   The data shown here are for experiments conducted with HEK293 cells, 
which endogenously express both CXCR4 and IL-10R (Supplemental Figure S1), but the 
same results were also observed with two monocytic cell lines (Supplemental Figure S2).   
Taken together, these findings indicate that cmvIL-10 specifically enhances chemotaxis 
toward CXCL12.   !! 
IL-10R and Stat3 activation are required for cmvIL-10 to potentiate CXCR4 signaling.   
Since cmvIL-10 is known to bind to IL-10R and activate the JAK-STAT pathway, we 
investigated whether this pathway was required for cmvIL-10 effects on CXCR4 
signaling.  Calcium mobilization was examined in HEK293 cells pretreated with an IL-
10R neutralizing antibody, and cmvIL-10 was unable to enhance the CXCL12-induced 
response in these cells (Figure 2 A).  There was no effect on the ability of CXCL12 to 
mobilize calcium, demonstrating that though antibody did not impair CXCR4 function, 
IL-10R was required for cmvIL-10 to affect CXCR4 signaling activity.  This was also 
confirmed using siRNA treatment to knockdown IL-10R prior to the calcium flux assay 
(Figure 2 B).  A western blot verified that IL-10R expression was decreased (Figure 2 C), 
and in these cells, cmvIL-10 failed to increase CXCR4 signaling.  Next, cells were 
pretreated with either a chemical inhibitor of STAT3 (Figure 2 D) or siRNA to 
knockdown STAT3 (Figure 2 E,F) and assayed for calcium mobilization after stimulation 
with CXCL12 in the presence or absence of cmvIL-10.  While the response to CXCL12 
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was not affected by treatments that inhibited STAT3, cmvIL-10 was unable to augment 
CXCR4 signaling under these conditions.   Treatment with inhibitors of other signaling 
pathways did not interfere with the ability of cmvIL-10 to enhance calcium flux (Figure 2 
G) suggesting that STAT3 is a critical mediator of cmvIL-10 effects on CXCR4.  Finally, 
a transwell migration assay was performed using cells treated with either the Stat3 
inhibitor or a p38MAPK inhibitor (Figure 2 H).  Untreated cells migrated toward 
CXCL12, and migration was increased in the presence of cmvIL-10.  The enhanced 
migration effect by cmvIL-10 was completely ablated when cells were treated with the 
STAT3 inhibitor, whereas the p38MAPK inhibitor had no effect.  These results 
demonstrate that cmvIL-10 acts through the IL-10R/Stat3 signaling pathway to increase 
calcium signaling and migration by CXCR4. 
 
cmvIL-10 mediates a greater calcium flux and chemotaxis than hIL-10 in response to 
CXCL12  
To examine whether cmvIL-10 can act as a more potent chemo-kinetic agent than human 
IL-10, calcium flux assays were performed as described previously but here hIL-10 was 
included.  Results showed that hIL-10 can enhance CXCR4 calcium flux, but the 
response was greater in the presence of cmvIL-10 (Figure 3 A).  We also wanted to 
examine the combined effects of hIL-10 and cmvIL-10.  Results showed a modest 
additive effect when both were added compared to cmvIL-10 alone, suggesting that both 
are competing to bind the IL-10 receptor and inducing a quicker and stronger secondary 
effect.  In addition, we wanted to compare the downstream signaling effects of hIL-10 
and cmvIL-10 on chemotaxis and performed the same migration experiment as described 
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previously.  In HEK293, hIL-10 enhanced CXCR4-directed migration than CXCL12 
alone, but chemotaxis was even greater in the presence of cmvIL-10 (Figure 2 B).  
cmvIL-10 also enhanced CXCR4-directed chemotaxis more than hIL-10 in the monocytic 
U937 cell line (supplemental figure S2).  To confirm that STAT3 is getting 
phosphorylated, levels of phosphorylated STAT3 levels were immunoblotted and 
detected through western blotting.  Phosphorylated STAT3 levels were detected after 15 
minutes of treatment with hIL-10, cmvIL-10, or both at the expected size of 86 kDa, 
while total STAT3 levels were detected at the expected 91kDa (Figure 2 C). 
Phosphorylated STAT3 was not detected in untreated or in cells treated with CXCL12 
alone.   
 
cmvIL-10 does not affect CXCR4 gene expression  
One possible explanation for the increased CXCR4 signaling observed in the presence of 
cmvIL-10 was that CXCR4 gene expression was up-regulated.  To evaluate CXCR4 
mRNA levels, cmvIL-10 was added to HEK293 cultures for 2 hours or 24 hours.  RNA 
was isolated and both RT-PCR and quantitative PCR performed.   There was no change 
in CXCR4 band intensity (Figure 4 A) at either time point, indicating that cmvIL-10 did 
not impact CXCR4 gene expression.   Likewise, there was no change in total cellular 
CXCR4 protein levels, as determined by western blotting of cell lysates (Figure 4 B).   
These results are consistent with a previous report that hIL-10 enhancement of CXCR4 
signaling found no evidence of up-regulation of CXCR4.  
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cmvIL-10 and US27 synergize to enhance CXCR4 calcium flux and migration while 
US27effects are Stat3-independent 
Previous work in our lab showed that HCMV US27 can enhance CXCR4 activity [38], 
and here we wanted to see if cmvIL-10 and US27 could synergize to enhance CXCR4 
signaling than either viral protein alone.  To examine whether cmvIL-10 and US27 can 
synergize to enhance CXCR4 calcium flux, the same assay was performed as described 
previously, but here we compared HEK293 and 293-US27 cells.  Results showed that 
293-US27 cells caused a greater CXCL12-induced calcium flux in the presence of 
cmvIL-10 than in parent HEK293 cells (Figure 5 A), suggesting that cmvIL-10 and US27 
can synergize to potentiate CXCR4 activity.  Interestingly, cells pretreated with STAT3 
inhibitor did not block US27-mediated potentiation of CXCR4 in the presence of cmvIL-
10, suggesting STAT3 is not required for the effects of US27 (Figure 5 A).  In addition, 
migration assays were performed as described previously but here we compared 293-
US27 cells to 293-US28 and HEK293 cells.  Results showed that cmvIL-10 and US27 
synergize to enhance calcium flux (Figure 5 B) and chemotaxis (Figure 5 C) greater than 
both 293-US28 and HEK293 cells.  Basal movement without CXCL12 was comparable 
in both cell lines in the presence of cmvIL-10.   
 
cmvIL-10 and US27 synergy does not happen in trans 
  
To examine whether the cmvIL-10 and US27 synergy occurs in trans, we labeled cells 
with Fluo-4 AM dye and performed calcium flux in the presence of unlabeled cells.   
When we loaded the labeled HEK293 cells with US27 unlabeled cells for calcium flux in 
the presence of cmvIL-10, the response was not as high compared to US27 labeled cells 
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(Figure 6).  The US27 labeled cells were still able to induce a significant increase of 
calcium flux in the presence of cmvIL-10 either in combination with US27 unlabeled or 
HEK293 unlabeled cells.  This suggests that the synergy of cmvIL-10 and US27 on 
CXCR4 activity is specific to US27 being present on the same cell with both CXCR4 and 
IL-10R.   
 
cmvIL-10 enhances CXCR4 activity in infected with AD169 lab strain and TB40/E 
clinical strain 
To examine the effect of CXCR4 signaling during HCMV infection,  
Human foreskin fibroblast (HFF-1) and newborn human foreskin fibroblast (NUFF) cells 
were infected with either the AD169 strain of HCMV at an MOI of 0.25 for 48 hours or 
TB40/E clinical strain and US27 deletion mutant at an MOI at 0.25 for 96 hours.  
Infected cells exhibited a 40-45 % CPE at time of harvest for calcium flux assay.  
Infected HFF-1 cells exhibited a greater CXCL12-induced calcium response in the 
presence of cmvIL-10 than CXCL12 alone (Figure 7 A).  Interestingly, to further 
corroborate the cooperation of US27 and cmvIL-10 on CXCR4 activity in the context of 
virus infection, infected NUFF cells of the TB40/E and US27 deletion mutant were 
harvested for calcium flux.  TB40/E showed a significant increase in calcium flux in the 
presence of cmvIL-10, while US27 deletion mutant had a lower and comparable response 
to uninfected cells (Figure 7 B).  TB40/E also showed greater chemotaxis in the presence 
of cmvIL-10 compared to controls (Figure 7 C).  HCMV IE1 gene expression served as 
positive control to ensure the fibroblast cells were infected with the virus (Figure D).  IE1 
gene expression was detected in infected, but not in mock-infected cells.  US27 gene 
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expression was detected in only TB40/E virus-infected cells, while UL111A gene 
expression was detected in both TB40/E and TB40/E and US27 deletion mutant infected 
cells. 
 
US27, IL-10R, and CXCR4 are in close proximity to each other and form heteromeric 
complexes  
Proximity ligation assay was used to examine whether US27, IL-10R, and CXCR4 are in 
close proximity to each other.  Primary antibodies were used to detect for native proteins.  
Oligonucleotide-conjugated secondary antibodies served as plus and minus probes.  If the 
probes are within 15-30 nm of each other, they will ligate and amplify as a fluorescent 
amplicon.  Results showed that in US27 cells, each pairwise receptor exhibited discrete 
spots inside and around the cell, indicating US27, IL-10R and CXCR4 are all in close 
proximity to each other and thus possibly form heteromeric complexes and get 
internalized together (Figure 8).  In US27 cells, they exhibited significantly more IL-
10R:CXCR4 complexes than HEK293 cells, suggesting all three receptors are forming a 
large signaling complex allowing for the cmvIL-10 and US27 synergy to take place.  
Oncostatin M served as a negative control receptor to confirm that CXCR4, US27, and 
IL-10R do not form complexes with any surface receptor.    
 
Bone marrow tissue highly expresses both IL-10R and CXCR4 
To confirm the expression of CXCR4 and IL-10R in the bone marrow, we stained 
paraffin sections with antibodies to both receptors.  We visualized the tissue sections 
under confocal microscopy and found that the bone marrow has high expression of both 
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CXCR4 and IL-10R on the same cell (Figure 9).  After visualizing the sections under 
confocal microscopy, we de-stained the sections for immunohistochemistry analysis.  We 
stained the sections with hematoxylin and eosin (reagents provided by Dr. John Sullivan, 
University of San Francisco) to stain the nuclei and cytoplasm, respectively.  Red blood 
cells are stained intensely red.  We visualized the sections using SPOT Advanced 
imaging software under a compound microscope.  Our images show that the bone 
marrow consists of many different types of cells, including macrophages, 
megakaryocytes, and red blood cells.  This suggests that CXCR4 can direct migration of 
a variety of cell types to the bone marrow to further promote HCMV latency.  
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Discussion 
 
The successful co-existence of HCMV with its host is intricate and complex.  The virus is 
very widespread in the human population and can cause debilitating disease in the 
immune-compromised.  HCMV has evolved many strategies to manipulate the host 
immune system and establishes lifelong latency.  One way is by encoding cmvIL-10, a 
viral homolog of human interleukin-10 (IL-10).   Despite its low 27% homology to 
human IL-10, cmvIL-10 can bind and signal through the IL-10 receptor [55].  Moreover, 
studies have found that cmvIL-10 can exhibit the same immunosuppressive properties as 
human IL-10 [56].  
 
Studies have shown that human IL-10 can potentiate the signaling activity of cellular 
chemokine receptor, CXCR4 [54].  CXCR4 exhibits many physiological roles, including 
chemotaxis, embryogenesis, and the immune response [40].   CXCR4 is also considered 
to be the most common chemokine receptor found to be present in cancers, such as 
breast, prostate and lung cancer [68, 69].  Since human IL-10 has been shown to enhance 
signaling of CXCR4, we investigated whether cmvIL-10 can also augment CXCR4 
signaling.  Because cmvIL-10 signals via interaction with the human IL-10 receptor, it 
was first necessary to identify cells that express both CXCR4 and the human IL-10 
receptor in order to investigate whether cmvIL-10 has the ability to enhance CXCR4 
signaling.  Using HEK293, 293-US27 stable, THP-1, and U937 cells, we evaluated the 
presence of both receptors via flow cytometry.  Our results showed both receptors are 
expressed on the cell surface, confirming that these cell lines are good candidates for 
exploring the role of cmvIL-10 on CXCR4 signaling (supplemental figure S1).  Our 
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results showed that cmvIL-10, like human IL-10, can enhance the signaling activity of 
CXCR4.  Multiple cell lines stimulated with CXCL12 in the presence of cmvIL-10 
exhibited a significant increase in calcium mobilization (Figure 1, S2).  These results are 
noteworthy and may open the doors to some significant implications for HCMV 
modulation and dissemination.  It could be that cmvIL-10 binding to the IL-10 receptor 
activates a large signaling complex that enhances ligand CXCL12 mediated signaling 
through CXCR4.  Among the many physiological roles of CXCR4 is that it can direct 
immune cells to the bone marrow [70], a primary site of HCMV latency [71].  We also 
found that cmvIL-10 can also affect downstream signaling such as chemotaxis, which 
could shed light on a specific strategy that HCMV employs to target virus-infected cells.  
 
Proximity ligation showed US27, IL-10R, and CXCR4 to form heteromeric complexes 
and possibly suggest they’re getting endocytosed together and localizing to certain 
organelles.  Recent studies have shown that CXCR4 undergoes rapid CXCL12 mediated 
internalization onto the early endosomal compartments [72].  Moreover, US27 has been 
shown to localize to the endosomes and golgi apparatus, further suggesting that 
US27:CXCR4:IL10R are getting endocytosed together.  Studies have also shown that 
ubiquitin can function as a ligand for CXCR4 [42].  These findings suggest that cmvIL-
10 might be causing CXCR4 to be rapidly internalized and being targeted for lysosomal 
degradation through a pathway involving ubiquitination.  Moreover, cmvIL-10 may be 
playing a role in regulating the endosomal sorting of activated CXCR4 by targeting the 
receptor to the endosomal sorting complex required for transport pathway.   
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We also confirmed that the IL-10 receptor and STAT3 activation are required for the 
cmvIL-10-mediated enhancement of CXCR4 activity (Figure 2).  These results suggest 
that HCMV exhibits two distinct mechanisms in potentiating CXCR4 signaling (Figure 
10).  US27 and CXCR4 can be possibly forming heterodimers, while there might be some 
receptor crosstalk through the IL-10R involving STAT3.  Moreover, cmvIL-10 caused a 
greater enhancement of CXCR4 calcium flux and chemotaxis than human IL-10.  Recent 
studies have shown that human IL-10 can generate functional decoy receptors in the 
chemokine system [73].  In an inflammatory environment, these decoy receptors can act 
as molecular sinks for chemokines and prevent signal transduction.  Specifically, studies 
found that CCR1, CCR2, and CCR5 were retained on the cell surface of IL-10 treated 
cells and can trap inflammatory cytokines, removing them from the inflammatory site 
[73].  These receptors are essentially “frozen” chemokine receptors that are uncoupled 
and unable to elicit migration. Hence, decoy receptors can inhibit the chemokine receptor 
switch.  Moreover, CXCR4 has been suggested to be involved in certain inflammatory 
disorders [74, 75].  These findings suggest that in an inflammatory environment, cmvIL-
10 can possibly act as a decoy cytokine and disturb the CXCL12 binding to CXCR4.  
Hence, cmvIL-10 can possibly disrupt normal CXCL12-mediated effects.  
 
cmvIL-10 is a very intriguing viral homolog of HCMV, one that the virus employs to 
evade the immune system.  Despite its low homology to human IL-10, cmvIL-10 has 
been shown to bind the IL-10 receptor and exhibit the same immunosuppressive 
properties.  Furthermore, cmvIL-10 has been found to activate the same pattern of 
STAT1 and STAT3 DNA-binding complexes that was characteristic of IL-10 signaling 
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[55].  Moreover, human IL-10 has been shown to potentiate the chemotactic effect of 
CXCL12, while other cytokines such as IL-5, IL-6, and IL-9 do not [54].  Since we found 
that cmvIL-10 and US27 can synergize to enhance CXCR4 signaling (Figure 5), this 
suggests that cmvIL-10 may be the main viral cytokine acting as a chemokinetic agent, 
potentiating the chemotactic effect of CXCL12.  This synergy was specific to US27 and 
not US28.  The increased signaling of CXCR4 can further promote the directed cell 
movement of HCMV-infected cells to tissues expressing CXCL12 (Figure 11).  These 
virus-infected cells can be directed to the bone marrow and help facilitate viral latency.  
Consequently, a new round of infection can be initiated and expand the reservoir of 
latently infected cells.  In addition, CXCL12 is highly expressed in the placenta, thus it 
can attract virus-infected CXCR4-expressing cells into the maternal circulation and 
promote virus dissemination during placental development [76, 77].   
 
The wide range of physiological and pathological effects CXCR4 exhibits makes it 
intriguing to study.  Furthermore, examining the role cmvIL-10 may play in HCMV 
infection can help contribute to the understanding of how the virus can employ strategies 
to manipulate host cellular functions.  Little is known about US27 and since we found 
that cmvIL-10 and US27 act in synergy to potentiate CXCR4 signaling, it would be 
exciting to further explore the mechanism between these two viral gene products and 
other downstream effects on CXCR4 signaling.  Data produced from this research can 
possibly serve as the foundation for future follow-up studies in vivo and help clarify the 
role of cmvIL-10 in HCMV latency and develop better treatment options for preventative 
or antiviral therapy. 
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Materials and Methods 
Cell Lines and Tissue Culture 
Human embryonic kidney (HEK293, American Type Culture Collection, Manassas, VA) 
cells and HeLa (human cervical adenocarcinoma, ATCC) cells were grown and 
maintained in Eagles Minimal Essential Media (MEM) (VWR, Arlington Heights, IL) 
with 10% FBS (Atlanta Biologicals, Lawrenceville, GA).  HEK293 cells stably 
expressing HCMV US27 and US28 encoded in the p3X-FLAG vector (Sigma-Aldrich, 
St. Louis, Missouri) were maintained in MEM + 10% FBS with 1mg/ml Geneticin 
(Gibco, Grand Island, NY).  Suspended monocytic cell lines THP-1 (acute monocytic 
leukemia, ATCC) and U937 (human leukemic monocyte lymphoma, from Dr. Jonathan 
Jarvik, Carnegie Mellon University) were grown in RPMI media supplemented with 
200mM glutamine, 100X glucose, 1M HEPES, 100mM sodium pyruvate, 7.5% sodium 
bicarbonate, and 10% FBS.  All cells will be subcultured twice weekly by washing with 5 
ml of Dulbecco Phosphate Buffered Saline (DPBS), followed by 1 ml of 0.25% Trypsin-
EDTA (VWR) to detach HEK293 cell lines from flask.  All cells were maintained at 
37°C in a humidified incubator with an atmosphere of 5% CO2. 
 
Flow Cytometry 
Cells were harvested at 75-80% confluence by using cell stripper (VWR) and re-
suspended with MEM + 10% FBS.  Cells were then spun at 1000 rpm for 5 minutes at 
room temperature.  Cell pellets were then re-suspended with cold FACS buffer (PBS + 
1%BSA + 0.1% NaN3) and transferred into a clear round-bottom 96-well plate in a total 
volume of 100 µl per well.  Cells were incubated with anti-CXCR4-PE mouse antibody 
Tu,$Carolyn$
! 65!
(BD Biosciences), IgG2B-PE mouse isotype control antibody (R&D Systems), anti-IL-
10Rα-PE goat antibody (R&D Systems), or IgG-PE goat isotype control antibody (R&D 
Systems) for one hour on ice, protected from light.  For double-staining cells with 
CXCR4 and IL-10R, cells were co-stained with anti-CXCR4-PE mouse antibody and -IL-
10R antibodies followed by anti-goat FITC antibody (Santa Cruz Biotechnology).   
After an hour, cells were washed with 100 µl cold FACS buffer, and pelleted at 1000 rpm 
at 4°C for 5 minutes.  Cells were washed for a total of three times.  Cell pellets were re-
suspended in FACS buffer followed by the addition of 2% paraformaldehyde.  Surface 
staining of samples were deteced using a BD FACSCalibur flow cytometer (BD 
Biosciences).    
 
Calcium Flux Assay   
HEK293 cell lines were washed with PBS and harvested via cell stripper (VWR) and 
RPMI 1640 (Roswell Park Memorial Institute) medium without L-glutamine and phenol 
red (VWR) with 25 mM HEPES (VWR).  Cells were spun at 1000 rpm for 5 minutes at 
room temperature, pellets with washed and spun again followed by a re-suspension of 2 
ml RPMI + 25 mM of HEPES at a density of 5 x 105 cells/ml per sample.  For each 
sample, 2 µl of Fluo-4AM (Invitrogen, Grand Island, NY) were added and immediately 
covered with foil to protect from light.  Samples were incubated at 37°C with an 
atmosphere of 5% CO2 for 30 minutes with agitation at 10-minute intervals.  Following 
incubation, samples were spun at 1000 rpm for 5 minutes at room temperature with 
pellets re-suspended in RPMI + 25 mM HEPES and transferred into eppendorf tubes.  
Un-stimulated cells were collected for 20 seconds followed by addition of CXCL12 
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(0.1µg/ml) in the presence or absence of cmvIL-10 (0.1µg/ml).  For Stat3, PI3K, and 
p38MAPK inhibitors, HEK293 cells were pre-incubated with 10µM of each inhibitor 
followed by calcium flux.  DMSO served as a negative control for the inhibitors.  For IL-
10R neutralization studies, cells were pre-incubated with 30µg/ml neutralizing antibody 
for 30 minutes followed by calcium flux.  For Stat3 and IL-10R knockdown, HEK293 
cells were seeded at 1.5 x 105 cells per well in a 6-well plate followed by transfection 48 
hours later with either 30 pmol control siRNA (Cell Signaling), IL-10R siRNA (Santa 
Cruz Biotechnology), or Stat3 II siRNA (Cell Signaling) using Lipofectamine 
RNAiMAX transfection reagent (Invitrogen).  After 72 hours, cells were harvested for 
calcium flux assay with or without cmvIL-10 treatment.  Calcium flux was monitored 
using a BD FACSCalibur and BD Accuri C6 flow cytometer (BD Biosciences).  
Fluorescence units were analyzed using FlowJo software v9.4.9 (FlowJo, Ashland, 
Oregon). FACSCalibur flow cytometer (BD Biosciences, San Jose, CA).  In all calcium 
flux assays, ionomycin (VWR) served as the positive control to ensure cells were healthy 
and able to exhibit a calcium flux, while PBS served as a negative control to ensure that 
the addition of stimulus did not impact response.   
 
Cell Migration Assay  
Cells were harvested via cell stripper (VWR) followed by growth media and spun at 1000 
rpm for 5 minutes at room temperature.  Pellets were washed with PBS to eliminate any 
residual medium.  Cells were re-suspended at a density of 0.5 x 105 cells/well with media 
+ 0.5% FBS and 75 µl of cells were placed onto the upper chamber of a 96-well transwell 
system with 5.0 µm pores (VWR).  The bottom chamber contained 235 µl of media + 
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varying doses of CXCL12 in the presence or absence of hIL-10 (0.1 µg/ml) or cmvIL-10 
(0.1 µg/ml) in media + 0.5% FBS, each in triplicate.  For Stat3 and p38MAPK inhibitors, 
10 µM of inhibitor was added to the chemo-attractant media.  DMSO served as a negative 
control for the inhibitor.  Samples were incubated for four hours in a humidified 
incubator at 37°C with an atmosphere of 5% CO2.  Cells that traversed through the filter 
were harvested from the bottom chamber by the addition of CellTiter-Glo reagent 
(Promega, Madison, WI) with a two-minute incubation, shaking at room temperature 
followed by a 10-minute incubation on bench.  Luminescence was detected using a 
GloMax 96 Microplate Luminometer (Promega).  
 
RT-PCR  
Cells 75-80 % confluent were treated with CXCL12 (0.1µg/ml) in the presence of 
absence of cmvIL-10 (0.1 µg/ml).  RNA from cells was extracted using RNeasy Midi Kit 
(Qiagen, Valencia, CA). cDNA was prepared using the iscript cDNA synthesis kit (Bio-
Rad).  For PCR reactions, each contained cDNA template, primers, dNTP mix, Ex-Taq 
buffer, and Ex-Taq polymerase (Clontech, Mountain View, California) in a final volume 
of 30 µl.  The gene specific primers for CXCR4 were 5’ – 
CCGTGGCAAACTGGTACTTT – 3’ (forward) and 5’ – 
CCCTTGGAGTGTGACAGCTT – 3’ (reverse) and for B-actin specific primers, 5’ – 
AAGAGAGGCATCCTCACC – 3’ (forward) and 5’ – TACATGGCTGGGTGTTG – 3’ 
(reverse).  The gene specific primers for IE1 were 5’ - 
GGTCACTAGTGACGCTTGTATGATGACCATGTACCGA – 3’ and  
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5’ – GATAGTCGCGGGTACAGGGGACTCT – 3’ (reverse) and for US27 5’ –
GACGGACAAGCTTCGATGACCACCTCTACAAATAATC – 3’ (forward) and 5’ - 
CGACGAGCTGCAGTTACAACAGAAATTCCTCCTC – 3’ (reverse) and for UL111A 
5’ – TCCTGAGACAGCCGACTAATCACGGAC – 3’ (forward) and 5’ – 
TCTCGAGTGCAGATACTCTTCGAGACGG – 3’ (reverse).  The PCR reaction 
underwent the following protocol on a MyCycler Thermal Cycler (Bio-Rad): 94C, 5 min; 
35 cycles: 94C for 30 sec, 58C for 30 sec, 72C for 60 sec; 72C for 5 min; a final hold at 4 
°C.  The PCR products were visualized on a 2 % agarose gel.   
 
 
Western Blotting 
Cells were seeded into 10 cm dishes at a density of 8 x 105 cells and treated 48 hours later 
with CXCL12 (0.1 µg/ml) in the presence of absence of cmvIL-10 (0.1 µgat varying time 
points.  Cells were scraped in the dish via the addition of cold RIPA lysis buffer (25 mM 
Tris-HCL pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS), 
followed by PBS wash, and resuspension of pellet with 100 ul of cold RIPA buffer.  Cell 
lysates were agitated every 15 minutes for one hour, sonicated, and centrifuged at 14,000 
rpm at 4oC for 15 minutes.  Clarified cell lysates were then transferred into eppendorf 
tubes.  After the addition of 4X Laemmli buffer (Bio-Rad) and 10X sample reducing 
agent (Life Technologies), cell lysates were heated at 42oC for 10 minutes.  Samples were 
then separated using SDS-PAGE and transferred onto a nitrocellulose membrane as 
described above, followed by overnight incubation at 4oC with anti-CXCR4 goat 
polyclonal primary antibody (Santa Cruz Biotechnology) at a 1:100 dilution.  For 
detection, membrane was incubated with appropriate alkaline phosphatase-conjugated 
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secondary antibody.  Bands were visualized via the addition of Western Blue Substrate 
reagent (Promega, Madison, WI).   
 
Proximity Ligation Assay (PLA) 
Cells were seeded into 16-well chamber slides (Lab-Tek, Fisher-Scientific) at a density of 
1.5 x 105 cells per well and then treated 24 hours later with CXCL12 (0.1 µg/ml) in the 
presence of absence of cmvIL-10 (0.1 µg/ml) for 15 minutes in a humidified incubator at 
37°C with an atmosphere of 5% CO2. Cells were then fixed with 4% paraformaledyde for 
20 minutes at room temperature followed by a PBS wash for five minutes in a coplin jar 
with agitation then decant, three washes total.  Cells were treated with 0.5% Triton X-100 
in PBS for 10 minutes without agitation at RT then washed with 0.05% Tween-20 in TBS 
(TBS-T) for 3 x 5 min in a Coplin jar with agitation at RT.  Cells were blocked with one 
drop of Duolink blocking solution (1X) (DUOLINK PLA kit, Sigma-Aldrich) per well 
and incubated for 1 hour at 37°C.  After one hour, cells were co-stained with anti-CXCR4 
goat polyclonal antibody at 1:100, anti-IL10Rα rabbit polyclonal antibody (Santa Cruz 
Biotechnology) at 1:100, or anti-FLAG M2 mouse monoclonal antibody (Sigma-Aldrich) 
at 1:500 at 37°C for one hour.  Cells were washed with wash buffer A for 2 x 5 min in a 
Coplin jar with agitation at RT.  Cells were then co-stained with PLA probes PLUS and 
MINUS at 37°C for one hour.  Cells were washed with wash buffer A for 2 x 5 min, and 
incubated with ligation mix at a final dilution of 1:40 for 30 min at 37°C.  After 2 x 2 min 
washes with wash buffer A, cells were incubated with amplification mix at a final 
dilution of 1:80 for 30 min at 37°C.  Cells were washed for 2 x 10 min each in wash 
buffer B in Coplin jar with agitation followed by a one dip in 0.1X wash buffer B before 
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removing the silicone from the slide. Mounting medium with DAPI of 40 µl was added to 
the slide and coverslips were placed on top.  Slides were stored in the dark for 24 hours.  
Images were captured using a Zeiss LSM700 laser scanning confocal fluorescence 
microscope and Zen Black software (Carl Zeiss, Inc., Oberkochen, Germany).   
 
Bone marrow paraffin-embedded tissue staining  
Five-micron thick tissue sections (Zyagen, San Diego, California) were immersed in 
xylene 2 x 10 minutes in a coplin jar, shaking, followed by a series of ethanol 
concentrations: 2 x 10 min washes in 100% ethanol; 5 minutes each in 95%, 70%, and 
50% ethanol.  The tissue section was then rinsed in dH2O, then rehydrated with wash 
buffer (1X PBS) for 10 minutes followed by draining of the excess buffer.  Tissue 
sections were incubated with blocking buffer (1% horse serum in PBS) for 30 minutes at 
room temperature.  Primary antibodies CXCR4 mouse antibody and IL-10R rabbit 
antibody (1:100, Santa Cruz Biotechnology) were added to the tissue sections and 
incubated at 4°C overnight.  Tissue sections were washed in wash buffer 3x 15 minutes, 
followed by addition of secondary antibodies Alexa Fluor 514 and Alexa Fluor 594 for 
one hour at room temperature.  Tissue sections were washed in wash buffer 3 x 15 
minutes, followed by the addition of DAPI and coverslip.  Images were captured on a 
Zeiss LSM700 confocal microscope.  For de-staining tissue sections, they were immersed 
in 70% ethanol overnight to gently remove coverslip.  Tissue sections were immersed in 
hematoxylin for 5 min then rinsed with tap water for 20 minutes.  The tissue sections 
were immersed in 70% ethanol than 95% ethanol, each for three minutes.  Next, slides 
were immersed in 100% alcohol containing eosin for three minutes, followed by 3 x 3 
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minute immersions in 100 % alcohol.  Then, tissue sections were immersed 2 x 3 minute 
immersions in xylene, followed by addition of Permount mounting medium and 
coverslip.  Images were captured with oil immersion on a compound microscope using 
the SPOT Advanced imaging software.   
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Figure 1.  cmvIL-10 enhances CXCL12/CXCR4 calcium mobilization and migration in HEK293 cells.  A) 
HEK293 cells were loaded with Fluo-4 AM calcium indicator dye, then stimulated with 0.1 µg/ml of CXCL12 in 
the presence or absence of cmvIL-10 (0.1 µg/ml).  cmvIL-10 alone served as a negative control. Relative 
fluorescence intensity (RFI) was measured by flow cytometry.  Calcium flux showed cmvIL-10-mediated CXCR4 
potentiation is B) dose-dependent on cmvIL-10 and C) dose-dependent on CXCL12.  D) HEK293 cells were seeded 
in a 96-well plate at a density of 5 x 104 cells in the upper chamber of an 5.0 µm transwell filter.  Varying doses of 
CXCL12 in the presence or absence of cmvIL-10 (0.1 µg/ml) was placed in the lower chamber where indicated.  
After 4 ½ hours of incubation, cells that traversed the filter were harvested and quantified by CellTiter-Glo.  * 
indicates p < 0.05 by Student’s t-test. 
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Figure 2.  The IL-10 receptor and Stat3 activation are required for cmvIL-10 mediated potentiation of 
CXCR4.  A) HEK293 cells were pretreated with either A) IL-10R inhibitor (10 µM) or B) IL-10R siRNA (30 
pmol).  Calcium flux was measured following treatment with 0.1µg/ml CXCL12 in the presence or absence of 
cmvIL-10 (0.1µg/ml). C) Cells transfected with siRNA were lysed and immunoblotted with IL-10R antibody.  
MAPK served as a control for total protein levels.  HEK293 cells were pretreated with D) Stat3 inhibitor (10 µM) 
or E) Stat3 siRNA (30 pmol) and calcium flux was measured following treatment with 0.1µg/ml CXCL12 in the 
presence or absence of cmvIL-10 (0.1µg/ml).  F) Western blot confirming Stat3 knockdown. G) HEK293 cells 
were pretreated with 10 µM inhibitor and calcium flux was performed following treatment with 0.1µg/ml CXCL12 
in the presence or absence of cmvIL-10 (0.1µg/ml).  H) HEK293 cells were seeded and pretreated with 10 µM 
inhibitor in the upper chamber of a 5.0 um transwell filter in a 96-well plate.  Varying doses of CXCL12 in the 
presence or absence of cmvIL-10 (0.1 µg/ml) were placed in the lower chamber where indicated.  Migrated cells 
were quantified.  Error bars represent standard error, * indicates p < 0.05, ** p < 0.01 
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Figure 3.  cmvIL-10 enhances CXCR4 calcium flux and chemotaxis greater than hIL-10.  A) HEK293 cells 
were loaded with Fluo-4AM calcium indicator dye, then stimulated with CXCL12 (0.1µg/ml) in the presence or 
absence of cmvIL-10, hIL-10, or both (0.1µg/ml). Ionomycin served as positive control. PBS served as negative 
control. * indicates p < 0.05; ** indicates p < 0.005 by Student’s t-test.  B) HEK293 cells were seeded in a 96-well 
plate in the upper chamber of an 5.0 µm transwell filter.  Varying doses of CXCL12 in the presence or absence of 
cmvIL-10 or hIL-10 (0.1 µg/ml) was placed in the lower chamber where indicated.  Migrated cells were quantified.  
C) P-Stat3 levels were detected after 15 minutes of treatment with cmvIL-10, hIL-10, or both through western 
blotting.  Total Stat3 served as loading control.  * indicates p < 0.05 by Student’s t-test.   
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Figure 4.  cmvIL-10 does not cause changes in CXCR4 gene expression and protein levels but affects 
receptor levels.  HEK293 cells were treated with CXCL12 (0.1 µg/ml) in the presence or absence of cmvIL-10 
(0.1 µg/ml), or both at the indicated times. RNA was harvested and reverse transcribed into cDNA, followed by  
A) RT-PCR using primers against CXCR4.  B) Cells were lysed and CXCR4 protein level was detected through 
western blotting.  MAPK served as loading control.   C-D) As above, but cells were treated for 24 hours.  
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Figure 5.  US27 and cmvIL-10 synergize to enhance CXCR4-directed chemotaxis while US27-CXCR4 
calcium flux does not require Stat3 activation.   A) HEK293 and 293-US27 cells pretreated in the presence or 
absence of Stat3 inhibitor (10 µM) were harvested and loaded with Fluo-4AM, followed by CXCL12-induced 
calcium flux performed in the presence or absence of cmvIL-10 (0.1µg/ml).  B) Cells were harvested and loaded 
with Fluo-4AM, followed by CXCL12-induced calcium flux performed in the presence or absence of cmvIL-10 
(0.1µg/ml).  C) Cells were seeded in a 96-well plate at a density of 5 x 104 cells in the upper chamber of an 5.0 µm 
transwell filter.  Varying doses of CXCL12 in the presence or absence of cmvIL-10 (0.1 µg/ml) was placed in the 
lower chamber where indicated.  After 4 ½ hours of incubation, cells that traversed the filter were harvested and 
quantified by CellTiter-Glo.  * indicates p < 0.05; ** indicates p < 0.005 by Student’s t-test.  
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Figure 6.  cmvIL-10 and US27 synergy does not happen in trans.  HEK293 and US27 cells were harvested for 
calcium flux as previously described.  Cells were labeled with Fluo-4 AM calcium sensitive dye and calcium flux 
was performed in the presence of unlabeled cells as indicated.  Cells were loaded with CXCL12 (0.1µg/ml) in the 
presence or absence of cmvIL-10 (0.1µg/ml).   
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Figure 7.  cmvIL-10 enhances CXCR4 signaling in infected fibroblasts with strains AD169 and TB40/E.  A) 
Uninfected and HFF-1 infected with AD169 lab strain at an MOI of 0.25 for 48 hours.  Uninfected and NUFF infected 
with clinical isolate TB40/E or US27 deletion mutant at an MOI of 0.25 for 96 hours.  Cells were harvested and either 
B) labeled with Fluo-4AM for calcium flux assay with CXCL12 treatment in the presence or absence of cmvIL-10 (0.1 
µg/ml) or C) seeded in a 96-well plate at a density of 5 x 104 cells in the upper chamber of an 5.0 µm transwell filter.  
Varying doses of CXCL12 in the presence or absence of cmvIL-10 (0.1 µg/ml) was placed in the lower chamber where 
indicated.  After 4 ½ hours of incubation, cells that traversed the filter were harvested and quantified by CellTiter-Glo.  
D) IE1 mRNA expression confirmed virus infection of each strain, while beta-actin served as a housekeeping gene. 
Error bars represent standard error, * indicates p < 0.05, ** p < 0.01 
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Figure 8.  Proximity Ligation Assay of US27, IL-10R, and CXCR4.  Primary antibodies to each native receptor 
were used, followed by oligonucleotide-conjugated secondary antibodies that act as plus and minus probes. If 
probes are within 15-30 nm of each other, they will ligate and get amplified, resulting in discrete fluorescent spots 
when viewed by confocal microscopy. A) Each indicated paired receptor show to be in close proximity to each other 
and thus form heteromers in 293-US27 stable cells. B) Direct comparison of  IL-10R and CXCR4 heteromers in 
HEK293 and 293-US27 stable cells.  Quantification of fluorescent spots shown on the right.  C) Oncostatin M was 
used as a negative control. 
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Figure 9.  Schematic model of HCMV enhancing CXCR4 signaling.  HCMV exhibits two distinct mechanisms 
to enhance CXCR4 signaling.   
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Figure 10.  Schematic model of HCMV-infected cells being directed to tissues expressing CXCL12.   
cmvIL-10 + US27 enhance directed movement of HCMV-infected cells to tissues expressing CXCL12, such as the 
bone marrow and placenta, thereby promoting virus dissemination.   
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Figure 11.  Bone marrow tissue expresses  CXCR4 and IL-10R.  A)  Tissue sections were immersed in xylene, 
followed by a series of ethanol concentrations; 100%, 95%, 70%, 50%, dH2O, then wash buffer to rehydrate the 
sections.  Slides were incubated with blocking buffer for 30 minutes at room temperature.  Primary antibodies 
CXCR4 mouse antibody and IL-10R rabbit antibody (1:100, Santa Cruz Biotechnology) were added to the tissue 
sections and incubated at 4°C overnight.  Cells were washed in wash buffer followed by addition of secondary 
antibodies Alexa Fluor 514 and Alexa Fluor 594 for one hour at room temperature.  Cells were washed and DAPI 
were added to stain the nuclei.  Images were captured on a Zeiss LSM700 confocal microscope.  Images show 
IL-10R (red), CXCR4 (green), and nuclei (blue).  B)  Tissue sections were de-stained with hematoxylin for 5 min, 
washed with tap water, followed by 70% ethanol, then 95% ethanol, each for three minutes.  Next, slides were 
immersed in 100% alcohol containing eosin for three minutes, followed by three 100% alcohol washes and two 
washes of Xylene.  Images were captured with oil immersion on a compound microscope using the SPOT 
Advanced imaging software.   80 
Supplemental figure 1 (S1).  Human cells express both CXCR4 and IL-10R on cell surface.  Cells were stained 
with fluorochrome-conjugated anti-CXCR4 (mouse, FL-2) or anti-IL-10R (rabbit, FL-1) antibodies.  Fluorescence 
intensity was measured by flow cytometry. Double positive cells indicated as percentage.  Cell types are as follows:  
HEK293, epithelial cells; 293-US27 and -US28 stable cell lines; THP-1 and U937, monocytic leukemia cell lines.  
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Supplemental figure 2 (S2).  cmvIL-10 enhances CXCR4 calcium mobilization and migration in THP-1 and 
U937 cells.  A) THP-1 and B) U937 cells were loaded with Fluo-4 AM calcium indicator dye, then stimulated with 
0.1 µg/ml of CXCL12 in the presence or absence of cmvIL-10 (0.1 µg/ml).  cmvIL-10 alone served as a negative 
control. Relative fluorescence intensity (RFI) was measured by flow cytometry.  C) U937 cells were seeded in a 96-
well plate in the upper chamber of a 5.0 µm transwell filter.  Varying doses of CXCL12 in the presence or absence 
of cmvIL-10 or hIL-10 (0.1 µg/ml) was placed in the lower chamber where indicated.  Migrated cells were 
quantified.  * indicates p < 0.05 by Student’s t-test.  D) U937 cells were seeded and pretreated with 10 µM inhibitor 
in the upper chamber of a 5.0 um transwell filter in a 96-well plate.  Varying doses of CXCL12 in the presence or 
absence of cmvIL-10 (0.1 µg/ml) were placed in the lower chamber where indicated.  Migrated cells were 
quantified.   
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HCMV US27 enhances NFκB signaling 
 
 Studies have shown that CXCL12/CXCR4 can activate and promote translocation 
of NFκB to the nucleus, activating the NFκB signaling pathway [78, 79].  CXCR4 can 
also activate NFκB signaling and promote cancer cell migration and invasion [78, 79].  
We found that NFκB signaling is enhanced in the presence of HCMV US27.  We used a 
NFκB secreted luciferase reporter system to detect for the promoter activity.  Our 
findings show that US27 wild-type and cmvIL-10 can synergize to enhance NFκB 
signaling (Figure 1).  However, CXCL12 and cmvIL-10 also seemed to enhance NFκB 
signaling in control HEK293 cells.  
NFκB activity may cause certain cytokines to be expressed in immune cells, 
leading to STAT3 activation in both malignant and immune cells [80].  This suggests that 
NFκB may be activating cmvIL-10, leading to more STAT3 activation and causing more 
downstream signaling of STAT3.  The putative crosstalk between NFκB and STAT3 
include its physical interaction between the two and cooperation of the two at specific 
gene promoter/enhancer regions [80].  Since NFκB signaling can be activated by 
CXCR4, we propose increased signaling in the presence of US27.  More studies need to 
be done to understand the effects of US27 and cmvIL-10 on NFκB signaling.  For 
example, NFκB and STAT3 can control the regulation of certain anti-apoptotic, pro-
proliferative and immune response genes.  Some of these genes overlap and need the 
interaction of the two factors.  One future experiment may be looking at certain genes to 
see if there is a difference in expression in the presence of US27 and cmvIL-10.  !
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Figure 1.  HCMV US27 and cmvIL-10 synergize to enhance NFκB signaling.  Cells were seeded 
in a 96-well plate at 1.0 x 104 cells/well, followed by next day transfection with pMetLuc2-Control 
Vector or pNFκB-MetLuc2-Reporter Vector at 3:1 Fugene to DNA.  After six hours of post-
transfection, cells were treated as indicated.  Reporter activity was quantified with the addition of 
substrate at the indicated times.  
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The human cytomegalovirus US27 gene product binds to the cellular GABAA-receptor 
associated protein (GABARAP) We!employed!the!yeast!two?hybrid!system!to!screen!a!human!bone!marrow!library!and!identified!GABARAP!(gamma?aminobutyric!acid!type!A!receptor?associated!protein)!as!a!binding!partner!with!the!C?terminal!domain!of!US27.!!The!GABARAP!protein!contains!hydrophobic!binding!pockets!that!tend!to!associate!with!a!four!amino!acid!motif,!WXXL,!where!W!represents!the!amino!acid!tryptophan![81]!,!X!represents!any!amino!acid,!and!L!represents!leucine.!!GABARAP!is!a!14!kDa!protein!expressed!in!a!many!cell!types!and!has!roles!in!membrane!trafficking!and!fusion!events,!receptor!trafficking,!autophagy,!and!apoptosis![82].!Co?immunoprecipitation!assays!demonstrate!the!US27?GABARAP!interaction!in!HEK293!cells!(Figure!2).!!In!addition,!we!used!fluorescence!microscopy!to!examine!the!US27?GABARAP!interaction!in!human!embryonic!kidney!cells!(HEK293).!!Using!a!series!of!proteins!with!mutations!in!this!motif,!we!found!that!the!WXXL!motif!in!the!C?terminal!domain!of!US27!is!required!for!both!GABARAP!binding!(Figure!3)!and!for!localization!to!the!endosomes!(Figures!4).!!Mutation!of!the!tryptophan!(position!306)!and!leucine!(position!309)!residues!in!the!C?tail!of!US27!disrupts!its!binding!to!GABARAP!and!localization!to!the!endosomes.!!These!results!show!that!US27!functions!primarily!as!an!intracellular!protein!(Figure!5).!!Our!findings!suggest!that!the!viral!receptor!could!induce!internalization!of!cellular!chemokine!receptors!and!may!modulate!host!chemokine!signaling!responses.!!Future!work!includes!identifying!additional!proteins!that!are!part!of!the!US27?GABARAP!complex!with!the!aim!of!clarifying!the!role!of!US27!during!virus!infection.!
Figure 2.  Co-immunprecipitation with HCMV US27 and GABARAP.  293-p3XFLAG-US27 
stable cells were seeded in a 6-well dish at 2.0 x 105 cells, followed by immunoprecipitation using A) 
GABARAP antibody (1:100, Santa Cruz Biotechnology) and probing with anti-Flag M2 antibody 
(1:500, Sigma-Aldrich), or B) anti-FLAG M2 antibody and probing with GABARAP antibody.  
Western blot of glycosylated p3X-US27 is detected as a smear from 50-98 kDa in both the IP and cell 
lysate lanes, while GABARAP protein appears at 17 kDa.  * We have not been able to detect 
GABARAP in the co-IP lane with anti-FLAG IP antibody.  
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Figure 3.  US27 and mutants co-localize with GABARAP.  The US27 gene was cloned 
into the pEGFP vector to create a US27-EGFP fusion protein (green).  The GABARAP gene 
was cloned into the pDsRed vector to create a GABARP-DsRed fusion protein (red).  
HEK293 cells were seeded onto coverslips and transfected with both vectors.  After 48 
hours, cells were fixed and mounted using Prolong Gold with DAPI to stain nuclei blue.  In 
the merged image, areas of yellow represent co-localization (arrow).  
  US27 co-localizes with GABARAP; US27 mutants do not 
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Figure 4.  Wild-type US27 localizes to the endosomes.  HEK293 cells were seeded onto 
coverslips and transfected with GFP fusion vectors.  After 48 hours, cells were fixed and 
stained with antibodies to EEA1 (early endosome antigen 1) followed by TRITC-conjugated 
goat anti-rabbit antibody (red).  Blue represents the DAPI-stained nucleus, and green 
represents US27.  In the merged image, areas of yellow represent co-localization (arrow).  
US27 localizes to the endosomes; US27 mutants do not 
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Figure 5.  Schematic image of the US27 receptor binding to GABARAP and localizing 
to the endosomes inside a cell.  
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Discussion 
Human cytomegalovirus (HCMV) is a ubiquitous pathogen with seroprevalence 
that ranges 45-100 % worldwide [2].  The virus can lay dormant in healthy individuals 
but be life threatening in immune-compromised hosts.  In addition, successful co-
existence of HCMV with a healthy host is mediated by the production of viral proteins 
that mimic normal immune modulators like cytokines, chemokines, and chemokine 
receptors [17].   One such mimic is the US27 gene product, which has similar features to 
human chemokine receptors.  In this thesis, we focused on the US27 gene product and 
discovered that it can trigger several biological effects.  In chapter one, we found that 
cells expressing US27 showed enhanced growth rate compared to controls.  We also 
found US27 increased gene expression for JUN and FOS, indicating that US27 may 
induce changes in cellular gene expression through the action of the AP-1 transcription 
factor, thereby controlling cell proliferation and apoptosis [83].  US27 also increased 
BCL2L1 gene expression, which plays critical roles in regulation of cell survival.  These 
results suggest that like US28, US27 can stimulate cell division and promote enhanced 
growth during virus infection.  In summary, we found that during HCMV infection, US27 
can have a striking impact on cell gene expression and other host cellular functions.  
Next, we wanted to examine whether certain domains of US27 were required for 
the enhanced cell proliferation.  We found that the DRY motif and C-terminal domain of 
US27 mediate enhanced cell proliferation and survival.  We also found that wild-type 
US27 down-regulates CDKN1A, a negative regulator of cell proliferation.  This result 
suggests that US27 can drive cell proliferation by causing changes in host genes such as 
blocking CDKN1A.  In addition, cells-expressing US27 showed a down-regulation of 
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BTG2 and were impacted by modification of its carboxy-terminal domain (CTD), which 
suggests that US27 may be interacting with other host intracellular signaling proteins.  
Future work is needed to tease out the functions and signaling capabilities of this viral 
receptor, including whether these proliferative and pro-survival effects might play a 
possible role in tumorigenesis.  
Although no chemokine ligands for US27 have been identified, we found that 
US27 can synergize with cmvIL-10 to enhance the signaling activity of the human 
chemokine receptor CXCR4.  We also confirmed that the IL-10 receptor and STAT3 
activation are required for the cmvIL-10-mediated enhancement of CXCR4 activity.  
These results suggest that HCMV exhibits two distinct mechanisms in potentiating 
CXCR4 signaling.  US27 and CXCR4 can be possibly forming heterodimers, while there 
also might be some receptor crosstalk through the IL-10R involving STAT3.  In addition, 
cmvIL-10 caused a greater enhancement of CXCR4-mediated calcium flux and 
chemotaxis than human IL-10.  Moreover, proximity ligation showed US27, IL-10R, and 
CXCR4 to form heteromeric complexes and suggests all three receptors are endocytosed 
together to form one large signaling complex.  Furthermore, among the many 
physiological roles of CXCR4 is that it can direct immune cells to the bone marrow [70], 
which is a primary site of HCMV latency [71, 84] and thus could expand the reservoir of 
latently infected cells.  Chemotaxis in HCMV-infected cells may be significantly 
increased in the presence of US27 and cmvIL-10.   
Taken together, research detailed in this thesis found that US27 enhances cell 
proliferation, protect cells from apoptosis, and causes changes in host gene expression 
levels.  We identified that the DRY motif and C-terminal domain to be responsible for 
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US27-induced cell proliferation.  Since US27 can promote cell proliferation and 
synergize with cmvIL-10 to enhance CXCR4 activity, this suggests US27 can cause more 
HCMV-infected cells to be directed to the bone marrow and facilitate HCMV latency.  
HCMV remains the most common viral cause of birth defects and childhood disabilities 
in the United States [6]. Studies have shown that the decidual trophoblast cells that line 
the maternal blood vessels secrete CXCL12 [76, 77].  This suggests increased homing of 
HCMV-infected cells into the placenta, thereby attracting virus-infected CXCR4-
expressing cells into the fetal circulation.  
We also found that US27 can interact with cellular protein GABARAP, shown 
through preliminary co-immunoprecipitation and immunofluorescence microscopy.  
Specifically, we found that the WXXL motif of US27 is required for both GABARAP 
binding and localization to the endosomes.  GABARAP is expressed in a variety of cell 
types and has roles in membrane trafficking and fusion events, receptor trafficking, 
autophagy, and apoptosis [82].  These results indicate that US27 functions primarily as an 
intracellular protein and may alter host trafficking patterns.   
  CXCL12/CXCR4 has been shown to activate and promote translocation of NFkB 
to the nucleus, thereby activating the NFκB signaling pathway [78, 79].   Preliminary 
findings suggest that NFκB signaling is enhanced in the presence of HCMV US27.  Since 
NFκB signaling can be activated by CXCR4, we speculate increased signaling in the 
presence of US27.  Future studies need to be done to understand the effects of US27 and 
cmvIL-10 on NFκB signaling.   
Lastly, a different form of cmvIL-10 has also been identified, denoted latency-
associated cmvIL-10 (LAcmvIL-10) [85].  The LAcmvIL-10 homologue results from 
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alternative splicing and is among the few viral proteins synthesized during the latent 
phase of viral infection, possibly contributing to host immune evasion.  Future work may 
include examining the role of LAcmvIL-10 on CXCR4 signaling, in the presence or 
absence of US27.  
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